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The sterols are unsaponifiable lipids obtained from
the extraction of plant or animal tissues with organic
solvents. They consist of C27~C29 secondary alcohols
which are crystalline solids. In the tissues of the
vertebrates, cholesterol a ClT alcohol of the formula
C27H44O is the principal sterol.
The early work of Wieland, Windaus, Diels,
Rosenheim and King (see Fieser and Fieser, 1959, for
review) established the structure of cholesterol as
having a cyclopentanoperhydrophenanthrene nucleus
(three fused cyclohexane rings with a terminal cyclo-
pentane ring). As the chair form of cyclohexane is the
more stable conformation, the three rings appear to be
in chair forms. In the chair form of cyclohexane, two
types of substituents can be recognized: those joined with
an equatorial bond and those joined with axial (Hassel
and Ottar, 1947; Barton, 1950).
The substituents above the plane of the ring system
are called {3-substituents and those below the plane of
the ring are termed a - substituents. Substituents of
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unknown configurations are denoted by the Greek
letter £| . The subject of conformations of cyclohexane
'
rings has been reviewed by Klyne (1954), Barton (1953)
and Barton and Cookson (1956).
In cholesterol the cyclopentanoperhydrophenanthrene
ring system has two angular methyl groups at carbon 10
and carbon 13 and an iso-octane side chain is attached in
i the (5-position at Cjj. The hydroxyl group is at 3(5-
position. A diagrammatic representation of the structure
of cholesterol is given in Fig. 1.
In cholesterol there is a potential asymmetric centre
■ $
at carbon 5 and the reduction of the 5, 6-double bond may
! lead to two compounds - one, cholestanol, having the
introduced hydrogen in the a -position or trans to the
angular methyl groups, and the other, coprostanol, with
a 5fi-hydrogen. In cholestanol the rings B and C are
locked rigidly in the chair conformation by the trans
fusion to rings A and O but the ring A is free to assume a
different conformation. In coprostanol, since the 5-
hydrogen is p, the fusion of the rings A and B is cis and
the ring A assumes a different form. Nevertheless, it
has the chair conformation (Fig. 1). The work on
stereochemistry and nomenclature has been reviewed by
Klvn* f 1957).
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Cholesterol is found in all tissues both free and
esterified with higher fatty acids. The sterol fractions
obtained from various body tissues consist of a number
of other sterols beside cholesterol. These compounds
have been called 'cholesterol companions' (Fig. 2 )#
Cholest-5-en-3(3-ol (cholesterol) obtained from
tissue extracts has always been found to be contaminated
with these compounds. Cholest-5, 7-diene-3|3-ol was
isolated from pig skin (Windaus, 1936). Schoenheimer
indicated the presence of cholestan-3j3-ol which was later
isolated (Fieser, 1951) along with another companion
cholest-7-en-3J3-ol (Fieser, 1951; 1953; Idler and
Bauman, 1952), Cholest-5, 24-diene-3p-ol was isolated
from chick embryo (Stokes , Fish and Hickey, 1956)
and also from rat skin (Stokes, Hickey and Fish, 1958).
Cholesterol obtained from horse or human brain (Ercoli,
1953
de Frisco & de Ruggieri/) or from spinal cord
preparations contains cholest-5-en-3(3, 24p-diol.
Another companion 22a -hydroxycholesterol was isolated
From a lily (Stabursvik, 1953). Brain extracts yielded
cholesterol containing cholest-5-en-3(3, 25-diol and
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cholestan-3p, 5a, 6|3-triol but these two compounds
could very well be autoxidation products of cholesterol
since old samples of pure cholesterol have been shown to
have got contaminated with these autoxidation products.
Autoxidation
Cholesterol is readily oxidized in colloidal solutions
when exposed to excess oxygen. The chief products of
autoxidation (Fig. 3) isolated are cholest-5-en-3|3-ol-7-
one, Choiest-5-en-3(3, 7|3-diol and cholest-5-en-3P. 7a -
dioi (Bergstrom and Wintersteiner, 1941, 1942),
Choiestan-3f3, 5a, 6^-triol has also been isolated as an
autoxidation product (Danielsson, I960).
The mechanism of these oxidations is not known.
Since the oxygen used is molecular and the position 7,
allylic to the 5, 6-double bond, seems to be very sensitive
to these oxidations, Bergstrom suggested that these aut¬
oxidation products may be due to the formation of a
hydroperoxide at position 7 which could cleave in
presence of water or metal ions in biological systems
to give these products (Bergstrom, 1943).
The breakdown of hydroperoxides to keto- and
hydroxy- products is a well known phenomenon
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(Kornblum and De La Mare, 1951) and it is now known
that cholesterol can be photo*oxygenated at the allylic
position 7 to give 7a-hydroperoxides (Schenck> Gollnick and
Neumuller, 1958b). It seems that in these autoxidations
the molecular oxygen is trapped on to the allylic position
7 as OOH which is an unstable molecule and readily
cleaves to give the 7-oxygenated compounds and their
dehydration products.
However, this hydroperoxide formation does not
explain the autoxidative formation of cholestan-3j3, 5a,-
6p-triol. Brill (1963) showed the formation of trace
amounts of epoxides in his photo-sensitized oxygenation
reactions showing that in presence of a catalyst
molecular oxygen can be used to form an epoxide,
et.oL
Nickonj[( 1963) havemade this method quantitative for
preparation of some keto- and hydroxy-epoxides. It is
known that the reductive cleavage of epoxides gives
trans-diaxial products (Fieser and Fieser, 1959). It
would thus seem that the role of a 5, 6-epoxide as an
intermediate in the autoxidative formation of cholestan-
3)3, 5a, 6(3-triol can not be ruled out.
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Bile Acids
Gmelin (1828) isolated from non-saponifiable
portion of ox bile an acid, cholic acid. Several other
bile acids have been isolated by different workers.
uL
Bile acids are C34 saturated sterols, derived from
coprostane, having a c&rboxyl group at C24 and hydroxyls
at 3, 6, 7 and 12 positions. The positions of the
bile
I hydroxyls vary in different bile acids but all natural/hcids
have a hydroxyl group at 3a -position. The chemistry of
bile acids has been reviewed by Fieser and Fieser (1959),
Rodd (1953) and Shoppee (1958).
It is now known that bile acids are formed from
cholesterol in the animal organism. Although a number
of bile acids have been isolated, it is recognized that
cholic acid (3a, 7a, 12a-trihydroxycholanic acid) and
chenodeoxycholic acid (3a, 7a-dihydroxycholanic acid)
are the main or 'primary' bile acids in mammals,
formed from cholesterol. The work on the metabolism
of bile acids has been reviewed by Bergstrom,
Daniels son and Samuels son (1962).
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DEGRADATION
Cholesterol can be metabolized into various classes
of compounds in the tissues of the body. It has been
shown to be a precursor of steroid hormones, vitamin O,
bile acids and neutral sterols. Quantitatively the most
important pathway of degradation is the conversion to
bile acids and neutral sterols.
Lifschutz (1914) was the first to suggest the
possibility of formation of bile acids from cholesterol.
The investigations on the structures of cholesterol and
the bile acids, and the findings that a close similarity
existed between the two (Fig. 4 ). seemed to lend
support to Lifschutz's theory.
The first direct evidence that cholesterol was indeed
degraded to bile acids in the animal organism was
produced when labelled cholic acid was isolated from the
bile of a dog to which deuterium-labelled cholesterol had
been administered (Bloch, Berg and Rittenberg, 1943).
Similar experiments using rabbit (Kendahl and Sjovall,
1955) and rats (Bergstrom and Norman, 1953) produced
labelled bile acids from labelled cholesterol.
If, then, cholesterol is converted to cholic acid,
four changes in its structure must necessarily take place.
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A) Cleavage of the side-chain to give a C24-
! terminal carboxyl group,
B) Changes associated with the steroid nucleus.
i) Addition of hydroxyl groups at 7a and 12a-
positions,
ii) Saturation of the 5, 6-double bond to give a
5|3-hydrogen and so a cis-fusion of the rings A and B
(coprostan series),
iii) Epimerization of the 3p-hydroxyl group of
| cholesterol to 3a -hydroxyl of cholic acid.
.
The sequence in which these changes are brought
about is not yet known. Most studies on the sequence of
reactions involved in the degradation of cholesterol to
; bile acids, have been done on postulated synthetic
intermediates. Various in vivo and in vitro
techniques have been used but since the liver is capable
of oxidizing a variety of parenterally administered C27-
sterols to C24-acids (Hanahan and Wakil, 1953; Bergstrom,
1955), and this capacity is retained in in vitro
preparations, it is very difficult to say that the
compounds used in these systems are indeed inter¬
mediates in this degradation. Nevertheless, most
studies have utilized this approach involving 'possible
intermediates'.
There are two main pathways in which the above
mentioned changes could be brought about; either the
side-chain is cleaved before any other changes, or the
hydroxylations and the other structural changes
associated with the steroid nucleus will precede the
oxidation of the side-chain. If the side-chain was
oxidized first to give a C-24-carboxyl, 3p-hydroxy-
chol-5-enic acid would be an intermediate, but if the
steroid nucleus is modified before the oxidation of the
, side-chain 3a, 7a, 12a-trihydroxy-coprostane would be
an intermediate. Bergstrom (1955) showed that the
latter compound was rapidly converted into cholic acid,
in a bile fistula rat, while 3p-hydroxy-chol-5-enic acid
did not give cholic acid.
However, Usui and Yamasaki (I960) found that 3(3-
hydroxy-chol-5-enic acid was hydroxylated at position 7,
but these authors did not establish the configuration at
Cj of the product formed. It is partly due to the
| difficulty in preparing the 7-hydroxy-chol-5-enic acid.
This compound was first prepared by Haslewood (1934)
.
by chromic acid oxidation of 3fi-hydroxy- chol- 5- enic
acid and the subsequent reduction of the 7-ketone.
I
The configuration at Cy was, however, not established.
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It will be of considerable interest to establish whether
3p, la -dihydroxy-chol-5-enic acid is converted to bile
acids in say a bile fistula rat.
But, if in view of Bergstrom's experiments it is
assumed that the steroid nucleus is modified before the
complete oxidation of the side-chain, then there are
several possibilities.
i) That the 3f3-hydroxyl of cholesterol epimerizes
to 3o-hydroxyl of cholic acid before other changes.
I
ii) That the saturation of the 5, 6-double bond
precedes other structural changes.
Or iii) That hydroxylations at Cy and occur
before other changes.
The saturation of the 5, 6-double bond may occur in
situ or it may isomerize to position 4 and 5 before
saturation. Chemically the latter path would be more
suitable because it is known that reduction of 4, 5-
double bond gives more of the 5£~hydrogen, that is
compounds of the coprostan series (Grasshof, 1934;
Barton, 1949), while the reduction of 5, 6-double bond
gives compounds of the cholestane series (Hershberggt.aU
1951; Nace, 1951).
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The epimerization of the 3|3-hydroxyl may proceed
through a 3-keto derivative. If this was so, the H at 3a
and the H-atom of the OH-group would be lost during the
J course of the reaction. Also the 3-keto group would be
expected to shift the double bond from 5, 6 into the stable
position at 4, 5. In fact, Samuelsson (1963) has shown
that cholesterol labelled with tritium at position 3-alpha
lost its tritium during the course of its conversion to bile
acids which lends support to the contention that the
epimerization proceeds through a 3-keto intermediate.
If the epimerization of the 3-hydroxyl preceded the
other reactions, then cholest-5-en-3-one, cholest-5-en-
3a-ol, cholest-4-en-3-one or cholest-4-en-3a-ol would
be expected as intermediates while if the saturation
preceded other reactions, coprostan-3(3-ol, coprostan-3-
one and coprostan-3a-ol would be intermediates.
Harold, Jayko and Chaikoff (1955) and Harold et al. (1957)
used a number of these saturated and unsaturated compounds
with an oxygen function at carbon-3 in their bile fistula
I
rats and found that none of them was converted into cholic
acid. They concluded that the hydroxylations at C7 and/or ,
must precede the inversion of the 3-hydroxyl.
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Since the reduction of 4, 5 double bond leads to
compounds of the cbprostane series it would be of
interest to test cholest-4-en-3a-ol and coprostan»3»one
in these experiments.
7a -Hydroxylation
As an extension of Harold and Chaikoff's studies
Bergstrom and JLindstedt (1956) and JLinstedt (19574)
used labelled cholest-5-en-3p, 7a-diol and coprostan-
3a. 7a -diol in their experiments with bile fistula rat and
showed that both were converted into cholic and cheno-
deoxycholic acids. On the basis of these experiments
Bergstrom concluded that 7a-hydroxylation is an early
and essential step in the conversion of cholesterol to
bile acids.
As pointed out earlier, the position 7 is very
reactive and so it is very likely that the first step
towards the degradation of cholesterol to bile acids is
an attack at position 7. The complete mechanism of
this hydroxylation is not known and the enzyme or
enzymes catalysing this reaction have not been purified.
COPROSTAN-3-ONE-7«-OL 3i/.^»c-DlhYOROXY- CHOLANIC ACID




The subject will be discussed in a greater detail later
(p. 31). Again because of the sensitivity of this
position to autoxidation, studies on this initial
hydroxylation of the cholesterol molecule at C7 have
been difficult.
Cholesterol (Bloch et al. 1943; Bergstrom and
Norman, 1953; Kendahl and Sjovall, 1955) cholest-5-en-
3p, 7u -diol and coprostan-3a, 7a -diol (Bergstrom and
Lindstedt, 1956; Lindstedt, 1957a) cholest-4-en-3-one-
7a-ol, coprostan-3-one-7a-al (Danielsson, 1961a and b)
have been shown to convert into cholic and chenodeoxy-
cholic acids while compounds with some modifications in
the side-chain like cholest-5-en-3p, 26-diol, cholest-5-
en-3£, 7a , 26-triol (Danielsson, 1961d), coprostan-3a, 7a, -
26-triol (Berseus and Danielsson, 1963), 3a,7a-di-
hydroxy coprostanic acid (Bridgewater and Lindstedt,
1957) or 3a, 7a-dihydroxy-cholanic acid (Lindstedt and
Sjovall, 1957) all have been shown to convert into cheno-
deoxycholic acid and very insignificant amounts of cholic
acid (Fig. 4). These studies show that 12a-hydroxylation
does not occur once the oxidation of the side-chain has
started.
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Danielsson (1961e) studied the metabolism of
cholest-5-en-3p, IZa-diol in the bile fistula rat and found
that it was converted in part to cholic acid* but he pointed
out that this could be due to 7a -hydroxylation of deoxy-
cholic acid which could easily have formed from the
administered cholest-5-en-3|3, IZa-diol* To establish
the direct formation of cholic acid from 12a-hydroxy-
cholesterol the rabbit would be a suitable animal since in
this species deoxycholic acid can not be hydroxylated at
position 7 (Lindstedt and Sjovall, 1957;, Bergstrom et al. 1955).
From the evidence accumulated above that 3, 7-
dihydroxy compounds, saturated and unsaturated, are
converted to cholic acid while 12a-hydroxycholesterol
cannot be considered as a direct precursor of cholic
acid, it might be reasonable to assume that in the
sequence of hydroxylations of the nucleus 7a-hydroxylation
precedes the 12a-hydroxylation and that the 12a-
hydroxylation precedes any modifications of the side-chain
and also that 7a-hydroxylation can occur even after the
initiation of the oxidation of the side-chain.
-15-
Inversion of Configuration at Position 3 and Saturation
of the Double Bond
From the above discussion it seems that
hydroxylation at position 7 occurs before the inversion
of the 3f3~hydroxy! group and the saturation of the double
bond and also before the introduction of 12a -hydroxyl
group. Coprostan-3a, 7a-diol has been shown to be on
the pathway of degradation of cholesterol to cholic and
chenodeoxycholic acids (Lindstedt, 1957a). Thus, if
7a-hydroxylation occurs before 12a -hydroxylation and
the inversion of the 3p-hydroxyl, and also if the
inversion takes place via 3-keto derivatives as suggested
by Yamasaki £t al. (1959a) on the basis of their in vitro
studies (see also p. 11) then cholest-4-en-3-one-7a-ol
and coprostan-3-one-7a-ol can be postulated as inter¬
mediates. If the 3j3-hydroxyl is oxidized to a ketone
after the introduction of the 7a-hydroxyl, the 5, 6-double
bond would be expected to isomerize into 4, 5-position
almost simultaneously and the possibility of cholest-5-
en-3-one-7a-ol as a stable intermediate is remote.
Samuelsson's studies with 3a-SH-cholesterol (p. H)
and his suggestion (Samuelsson, 1959) that the saturation
-16-
of the 5, 6-double bond in the conversion of cholesterol to
chenodeoxycholic acid in pig is a stereospecific cis-
addition from the p-side of the molecule lend support to
Yamasaki's suggestion (aiSo Green and Samuelsson, 1964).
Danielsson (1961 a andb) showed that cholest-4-en-
3-one-7a-ol and coprostan-3-one-7a-ol were indeed
converted into both cholic and chexiodeoxycholic acids in
the bile fistula rat.
In vitro studies with cholest-5-en-3|3, 7a -diol using
mouse liver homogenates have shown that cholest-4-en-
3-one-7a-ol was one of the metabolites (Danielsson.
1961c). In the same experiments two other metabolites
were obtained one of which because of its spectral and
chromatographic properties was suggested to be cholest-
4-en-3-one-7a, 26-diol and the other was identified as
cholest-5-en-3p, 7a, 26-triol. The same triol was also
obtained when cholest-5-en-3£, 26-diol was used as the
substrate (Danielsson, 1961a).
Identical results have been obtained in rat liver in
vitro preparations (Boyd and Hutton, 1964). Using
cholest-5-en-3|3, 7a-diol as the substrate in rat liver
microsomal preparations, cholest-4-en-3-one-7a-ol was
POSSIBLE PATHWAYS OF DEGRADATION OFCHOLEST-5-EN-3p,7*-DIOL
Figure 5
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isolated as a product. Two other products were
obtained, one of them identified as cholest-5-en-3p, 7a, -
26-triol and the other suggested to be cholest-4-en-3-
one-7a, 26-diol (Fig. 5).
If cholest-4-en-3-one-7a-ol was metabolized to
I coprostan-3a, 7a -diol or chenodeoxycholic acid, the
I .
4, 5-double bond and the 3-ketone have to be reduced and
depending upon which of the two is reduced first,
cholest-4-en-3a, 7a-diol and coprostan-3-one-?u-ol
would be intermediates.
Coprostan-3-one-7a-ol has been shown to convert
into cholic and chenodeoxycholic acids in the bile fistula
rat (Danielsson, 196ld). Boyd and Hutton (1964)
isolated this compound when cholest-4-en-3-one-7a-ol
was used in their rat-liver in vitro preparations.
Coprostan-3a, 7a-diol, cholest-4-en-3a, 7a-diol and a
more polar compound suggested to be cholest-4-en-3-
one-7a-26-diol were also obtained.
Cholest-4-en-3a, 7a-diol would be expected to give
5{3-hydrogen on saturation by chemical catalytic
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convert into coprostan-3a, 7a-diol as readily as
coprostan-3-one-7a -ol (Boyd and Hutton, 1964). Thus,
it seems that the preferred path of epimerization of 3(3-
hydroxyl and the saturation of the double bond of cholest-
5-en-3(3, 7a-diol is through cholest-4-en-3-one-7a-ol
and the corresponding saturated compound coprostan-3-
one-7a-ol which on reduction gives coprostan-3a, 7a -
diol. All these compounds have been tested a3
precursors in the bile fistula rat and have also been
isolated in in vitro systems (Fig. 6).
12q-Hydroxylation
Up to date no compounds carrying a 12a-hydroxyl
group have been isolated from incubations of cholesterol
or other Cj* neutral sterols not already carrying a 12a -
hydroxyl. Consequently we do not know where on the
pathway of degradation the 12a -hydroxylation occurs.
On the evidence cited above it is clear that the 12a-
hydroxylation does not occur before 7a-hydroxylation
nor after the initiation of the oxidation of the side-chain.
Thus it could be considered to occur either before the
epimerization of the 3p-hydroxyl and saturation of the
double bond or after it. In the former case, cholest-
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5-en-3(3, 7a, 12a-triol would be an intermediate while in
the latter case coprostan~3a, 7a, 12a-triol would be an
intermediate. This latter compound has indeed been
shown to convert into cholic acid (p. 9 ), while the
former has not yet been synthesized to test in bile
fistula animals, nor has its formation ever been
indicated in any in vitro studies.
If cholest-5-en-3(3, 7a, 12a-triol was found to be an
I
intermediate and the epimerization and saturation
proceeded by the same series of reactions as for
cholest-5-en-3(3, 7a -diol, then cholest-4-en-3-one-7a, -
12a-diol, coprostan-3-one-7a, 12a-diol and coprostan-
—3a, 7a, 12a-triol could be postulated as intermediates.
If cholest-5-en-3p, 7a, 12a -triol is found not to be
l an intermediate, then 12a-hydroxylation may occur after
the initiation of the set of reactions involved with the
inversion at Cs and the saturation of the double bond.
In either case the above mentioned compounds would be
intermediates.(Fig. 7).
The fact that cholest-5-en-3{3, 7a-diol, cholest-4-
en-3-one-7a-ol, coprostan-3-one-7a-ol and coprostan-
3a, 7a-diol are all converted into cholic acid in the
bile fistula rat (p. 13 )» shows that a 12a-hydroxylation
-20-
can occur after any of these stages and thus supports
the hypothesis that the above mentioned compounds may
be intermediates.
Because of the marked difference in reactivity of
the hydrogen at Cj compared with of the cholesterol
molecule, hydroxylation reaction mechanisms at the
two centres may differ considerably. Hydroxylation at
Cf is easy and thus a number of 7a -hydroxylated inter¬
mediates have been synthesized by a direct introduction
of the oxygen function. The C^, on the other hand,
being saturated and sterically hindered, is difficult to
attack and that is why as a rule the syntheses of 12a«
' hydroxylated compounds start with a compound already
carrying a 12a -hydroxyl group, namely deoxycholic
acid (see also p. 31).
Structural Changes in the Side-Chain
As discussed in the preceding pages the structural
changes on the steroid nucleus seem to precede the
complete oxidation of the side-chain. The cleavage of
the side-chain may proceed by:
(i) a direct removal of the isopropyl group, a reaction
analogous to the cleavage of the cholesterol side-chain
by adrenal enzymes to yield pregnenolone and iso-
caproic aldehyde (Lynn et al. 1955; Staple et al» 1956),
or (ii) a gradual oxidation of the three terminal carbons,
or (iii) an initial oxidation at one of the terminal (c25> c26
or C27) carbons facilitating an attack at Cg4 leading to
p-oxidation at C24.
In the first case 24- or 25-hydroxy, 24, 25-dihydroxy
and 24-dehydro derivatives would be expected inter¬
mediates while in the latter two cases the initial attack
would be at one of the terminal carbons to give 26- or
27-hydroxyl and carboxyl derivatives followed by a
number of other oxygenated and dehydrated derivatives.
Since the most stable conformation of the side-chain
may be a straight chain structure (Fieser and Fieser,
1959), the terminal methyls at Cn and are the most
easily accessible of all the carbon atoms of the side-
chain, Thus it would seem that the initial attack on the
side-chain may be an omega-oxidation at one of the
terminal methyl carbons. This may be followed by
other oxygenations and dehydrations to give a Cl4
-22-
Studies on the mechanism of the cleavage of the
side-chain have indicated that an omega-oxidation is
probably the first step in this degradation; a number of
26-hydroxylated compounds have been isolated as inter¬
mediates in in vitro experiments and a number of 26-
oxygenated C27 steroids have been shown to be precursors
of bile acids in vivo.
Evidence for Omega-Oxidation (26-Hydroxylation)
Using cholesterol labelled at C2* with C14, it has
been shown that rat-liver slices (Meier et_al. 1952) or
cell free preparations of mouse liver (Horning et al. 1957)
can oxidize it to C14-labelled CO*. Whitehouse et al.
(1959) have also shown that mouse liver mitochondria
catalyse the oxidation of the terminal methyl group of
cholesterol to COj.
In this formation of COj, 26-hydroxy, 26-carboxy,
I
25-hydroxy and 25-dehydro compounds would be postulated
as intermediates. Fredrickson (1956) in his in vitro
studies with labelled cholesterol identified as products
26- and 25-hydroxylated derivatives along with some
unidentified acidic products. Labelled COz was also
evolved. Danielsson (1961d) using mouse liver
-23-
homogenates identified 26-hydroxycholesterol as a
metabolite of cholesterol. He also found that mouse
|liver mitochondria were much more active for this
reaction than were rat liver mitochondria.
Gurin and coworkers (Lynn et al. 1955; Whitehouse
et al. 1959) used a liver mitochondrial preparation which
they called 'cholesterol oxidase1 system and reported the
conversion of 26-Cl4-cholesterol to 25-dehydrocholesterol
(cholest-5, 25-diene-3p-ol).
I
Since the use of cholesterol as the substrate in in
vitro systems also leads to a number of autoxidation
products it is considered advantageous to perform the in
vitro studies on the possible intermediates rather than
cholesterol itself. Daniels son (1961c) studied the
metabolism of cholest-5-en-3(3, 7a-diol in mouse liver
homogenate and identified the 26-hydroxylated derivative.
cholest-5-en-3p, 7a, 26-triol as a metabolite along with
cholest-4-en-3-one-7a-ol. In the same system he also
.
found another metabolite which was suggested to be the
126-hydroxylated derivative of cholest-4-en-3-one-7a-ol.
These two 26-hydroxylated compounds were also formed
when cholest-5-en-3J3, 7a-diol was incubated with
-24
mitochondria plus the 'supernatant fraction' of rat liver
homogenate (Boyd and Hutton, 1964), Berseus and
Danielsson (1963) have reported 26-hydrpxylation of
coprostan-3a, 7a -diol.
Enomoto (1962) has shown the conversion of
coprostan-3a, 7a, 12a -triol to 3a, 7a, 12a -trihydroxy-
coprostanic acid, the main bile acid from cholesterol in
-
the toad, to proceed through coprostan-3a, 7a, 12a, 26-
! tetrol.
Staple and Gurin (1962) found that their'cholesterol
oxidase' system can oxidize coprostan-3a, 7a, 12a-triol
labelled at C^y with C14 to coprostan-3a, 7a, 12a„27-
| tetrol.
The same results were obtained in mouse and rat
liver homogenates (Danielsson, I960). Small amounts
of 3a, 7a, 12a-trihydroxycoprostanic acid were also
obtained. Suld et al. (1962) confirmed the findings of
the above two groups of workers and, in addition,
isolated labelled propionic acid from the side-chain.
Propionic would result from the cleavage of the Czt'Czs
bond of 3a, 7a, 12a-trihydroxycoprostanic acid. Staple
-25-
and Rabinowitz (1962) have isolated labelled 3a, 7a, 12a-
trihydroxycoprostanic acid from human subjects given
labelled cholesterol.
All the above mentioned experiments on the
mechanism of the cleavage of the side-chain have shown
an initial attack on Qt* giving 26-hydroxylated and
carboxy intermediates, A number of these 26-hydroxy
compounds have also been shown as precursors of bile
acids in bile fistula animals (p. 13).
Evidence for ft-Oxidation (24-Hydroxylation)
Whitehouse et al. (I960, 1961) incubated cholesterol-
26-C14 with liver mitochondrial preparations and under
certain conditions could isolate labelled acetone.
Using 26-C,4-cholesterol and 25- C14-cholesterol it was
shown that in both cases the acetone formed was labelled
indicating that the formation of acetone was due to a
direct cleavage of the CgA-Cgg bond.
If acetone formation was due to a pathway of
degradation of the side-chain 24- and 25-hydroxy-
cholesterols, 24, 25-dihydroxycholesterol and 24-
dehydrocholesterol are possible intermediates.
-26-
Fredrickson (1956) isolated 25- and 26-hydroxy-
cholesterols from cholesterol incubations with
I
mitochondrial systems of Anfinsen and Horning (1953)
, but when cholest-5-en-3(3, 25-diol was tested on bile
fistula rat. it did not yield cholic acid (Fredrickson and
| Ono, 1956).
It will be interesting to do the same studies with
cholest-5 - en- 3 24-diol.
Further Evidence for Omega-Oxidation
Studies with cholest-5, 24-diene-3p-ol have shown
that this compound could be regarded as a direct
; precursor of bile acids. Bile acid production in
Triparanol (MER-29) treated animals does not differ
markedly from untreated animals (Goodman et al. 1962a
| Blohm et al. I960). Since Triparanol is considered to
block the enzyme catalysing the hydrogenation of the
side-chain double bond (Cgg-Cgg) and so stop the bio¬
synthesis of cholesterol (Avigan et al. I960), these
experiments indicate that desmosterol (cholest-5, 24-
diene-3(3-ol) might be a direct precursor of bile acids.
-27-
In vitro studies with desmosterol using rat liver
mitochondria (Kritchevsky and Staple, 1962) have shown
that the side-chain may be oxidized to produce COj.
Goodman et al. (1962b) have confirmed these results
using mouse liver mitochondria (also Danielsson and Johansson, 1964),
Shimizu et al. (1959) found that coprostan-3a, 7a, -
12a-triol, coprostan-3a, 7a, 12a -triol-24-one and
coprostan-3a, 7a, 12a, 24-tetrol were all converted to
cholic acid in the bile fistula rat, but the rate of
production of cholic acid was much slower with the
latter two compounds. Whitehouse et al. (1961b) have
obtained essentially the same results in their in vitro
studies with rat liver mitochondrial systems. The
yield of CO* from coprostan-3a, 7a, 12a-triol was much
higher than from C34-substituted compounds. But in
the case of mouse, monkey and human liver mitochondria
the case was reversed; the 0*4-substituted compounds
coprostan-3a, 7a, 12a , 24-one and coprostan-3a ,7a,12a, -
24-tetrol were oxidized more readily than the coprostan-
3a, 7a, 12-triol. However, the same group of workers
(Staple and Rabinowitz, 1962) have isolated 3a, 7a, 12a-
trihydroxycoprostanic acid from the bile of a human
subject given labelled cholesterol.
-28-
All these experiments have been done on 3a, 7a, 12a
trihydroxy compounds. It would be interesting to
repeat such experiments with 3a, 7a-dihydroxy-
coprostanic compounds with oxygen functions at Cg* and
without them, and see if these compounds are converted
to chenodeoxycholic acid.
On the basis of the above information on the
oxidation of the side-chain, acetone formation may not
I be a major pathway in the degradation of the side-chain.
There are a number of experiments to show CQt
formation and Cjg-hydroxylation and also the ready
conversion of 26-oxidized compounds into bile acids
while there is not enough evidence to prove ready
conversion of Ggg-or Cgg-hydroxylated compounds to bile
acids. The acetone formation seems, at most, due to
a minor pathway of degradation of the cholesterol side-
I
chain. But it would be very interesting to investigate
further this pathway.
Thus, it seems that the first step in the degradation
of the side-chain is an omega-oxidation at the terminal
I
methyl group, followed by a p-oxidation to give the Cg*-
carboxyl of the bile acids. If an omega-oxidation was
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the first step of this cleavage of the side-chain,
depending upon at what stage of the reactions involved
with the modification of the cholesterol nucleus this
oxidation is brought about, a number of 26-hydroxyl
and 26-carboxyl derivatives can be postulated as
intermediates (see Fig, 8). A number of these compounds
have already been synthesized and tested as precursors
of bile acids (see pp, 13, 16 ) but there are a number of
others which have not yet been synthesized and so not
yet tested.
If the 26-hydroxylation occurs before 12a-
hydroxylation, the final product will probably be cheno-
deoxycholic acid (since 12a-hydroxylation does not occur
after 26-hydroxylation) and thus cholest-5-en-3{3, 7a, 26-
triol, cholest-4-en-3-one-7a, 26-diol, coprostan-3-one-
7a, 26-diol, and coprostan-3a, 7a, 26-triol would be the
possible hydroxylated intermediates while, if the 26-
hydroxylation occurs after the introduction of the 12a-
hydroxyl, cholest-5-en-3p, 7a, 12a, 26-tetrol, cholest-
4-en-3-one-7a, 12a, 26-triol, coprostan-3-one-7a, 12a,-
26-triol and coprostan-3a, 7a, 12a, 26-tetrol would be
intermediates. It cannot be said at what stage of the
modification of the nucleus the side-chain is attacked.
-30-
If a complete oxidation of the side-chain occurs during
the nuclear changes* then a number of corresponding
24-carbon Cj4-carboxylated compounds would be inter¬
mediates. If 3p-hydroxy-chol-5-enic acid can be
hydroxylated at Cj (Usui and Yamasaki, I960) then the
inversion at Cs and saturation of the double bond would
occur after this and thus a number of 24-carbon Cj4-
carboxylated compounds would be intermediates.
I
Daniels son and Johansson (1964) have shown that
, desmosterol (cholest-5, 24-diene-3(5-ol), when incubated
i with mouse liver in vitro preparations, gave a more
polar compound which was suggested to be the 26-
hydroxylated derivative of desmosterol. If desmosterol
was on the route of biosynthesis of bile acids from
cholesterol there is a possibility of a 25-hydroxylated
derivative being an intermediate which would give
desmosterol on dehydration (Dauben and Bradlow, 1950;
Ryer et al. 1950). If desmosterol is an intermediate
and also if 25-hydroxylation is a step in the degradation,
then a number of 25-hydroxylated and 24-dehydro
derivatives could be postulated (see also p. 39) as
intermediates.
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HYPROXYLATIONS OF CHOLESTEROL MOLECULE
In the metabolism of cholesterol it has been shown
that the cholesterol molecule is not completely oxidized
to COfe but undergoes enzymic reactions which degrade
it to a C24 structure, the bile acids, which are excreted
as the end product of cholesterol degradation. As
discussed in the preceding pages, this degradation is
brought about by a sequence of reactions involving
oxidations, dehydrations and reductions and possibly
proceeds through hydroxylated and other intermediates.
The positions of the cholesterol molecule which are
affected in this degradation are the carbons 3, 6, 7, 12,
24, possibly 25, and 26.
The mechanism of these hydroxylations is not known.
While all the carbons affected in these hydroxylations are
saturated, the position 7 is unique in being allylic to the
5, 6-double bond. Because of this difference in the
chemistry of the position 7 from others, there may be
different mechanisms for these two types of
hydroxylation and so in the animal organism two different
types of enzyme systems involved.
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For a number of steroid nucleus and side-chain
hydroxylations it is known that the oxygen used is in a
molecular state (for references see reviews by Talalay
(1957) and Tamm (1962)) and that a reducing enzyme
system is required (Brownie and Grant, 1956; Grant
and Brownie, 1956). Using cholesterol labelled in the
7a- and 7p-positions it has been shown that the 7a-
hydroxylation is a stereospecific reaction where the 7a -
hydrogen is replaced by a hydroxyl without an inversion
of configuration; the 7a -tritium was lost during the
course of the degradation of cholesterol to cholic acid
while when cholesterol-7$-H3 was used, the cholic acid
obtained was labelled (Bergstrom jet al. 1958). The
11a -hydroxylation is also the same type of reaction,
the hydroxyl replacing the hydrogen stereospecifically
(Corey et al. 1958; Hayano et al. 1958). There is
evidence that enzymatic hydroxylations at a saturated
carbon atom of a steroid proceed by direct replacement
of the hydrogen and not by hydration of olefinic
intermediates (Hayano and Dorfman, 1954).
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Discussing the 'mixed function oxidation' systems
Mason (1958) proposed a scheme for the enzymatic
oxygenations. He suggests that the oxygen is taken up
by an enzyme forming the hydroxylating intermediate,
the enzyme-oxygen complex, which supplies oxygen to
the substrate, A number of oxidizing enzymes are
known which can supply molecular oxygen directly to
the substrate (Hayaishi, 1956).
The combination of molecular oxygen with olefines
is a well known phenomenon but these reactions are
usually of a free-radical type and involve chain
mechanisms, but when the reactions are conducted
photochemically in dilute solutions in presence of a
sensitizing agent, chain reactions do not seem to occur.
(The subject has been reviewed by Walling, 1957;
Bergman and McLean, 1941; Schenck, 1952.)
It has been suggested (Schenck, 1957; Livingstone and
Owens, 1956; Oster et al. 1959; Nickon and Bagli,
1961) that for mechanistic discussion the photo¬
sensitized oxygenation reactions may be arbitrarily
divided into several stages. With the absorption of
-34-
light energy the substrate and the sensitizer molecules
are converted into the activated states; the sensitizer
then forms a sensitizer-oxygen complex which in turn
supplies oxygen to the activated centre of the substrate.
It has been shown for a number of olefines (Schenck et_
al. 1953; Schenck, 1957; Nickon and Bagli, 1961) that
this is a stereospecific replacement reaction, the
I
introduced hydroperoxide group replacing the removed
i
hydrogen. The attack in all the known cases of steroid
photo*oxygenations has been from the rear side of the
.
molecule, presumably because of the bulky stereo¬
chemistry on the p-side.
In view of the known stereospecific mechanism of
photo-oxygenation reactions where a sensitizing agent
could form a sensitizer-oxygen complex and supply
oxygen to the activated substrate there seems to be a
marked similarity between the mechanism of photo-
'
chemical oxidations and the biological oxidations.
If in the latter oxidations the oxygen is trapped on to
the enzyme as Oz ( O O ) and is then supplied to the
activated centre of the substrate, there is a possibility
of the intermediate formation of a steroid-hydroperoxide
I
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which being unstable is cleaved at once in the presence
of some reducing enzymes.
The position 7 being the most reactive of all it
would be possible that the first attack on the steroid
molecule is at C7 to form a 7a-hydroperoxide.
This mechanism could reasonably explain the ready
hydroxylation at C7, which is most easily activated
because of the allylic double bond, but it does not
explain the hydroxylations at saturated centres which
could only form a hydroperoxide if there is a system
existing in the animal organism which could activate the
substrate in these specific positions.
However, it is known that saturated hydrocarbons
can autoxidize in air to form hydroperoxides at
saturated centres also. This property has been shown
for straight chain as well as cyclic saturated hydro¬
carbons. n-Octane has been shown to produce a
hydroperoxide at the terminal methyl carbon (Pope,
Dykstra and Edgar, 1929). Autoxidation of n-decane
-36-
gave equimolar amounts of 2, 3, 4 and 5-hydroperoxides
with a trace of 1-hydroperoxide (Benton and Wirth,
1953; Pritzkow and Muller, 1955). cis-Decalin
produces the 9-hydroperoxide (Criegee, 1944) which
can be easily made by autoxidation of cis -decalin at
higher temperatures (170*) and reduced pressure.
Oleates of cobalt, manganese, zinc and cerium have
been shown to catalyse the reaction. Trans-decalin
I ' * 1 • • •• IV.: «' ' : . C «•' -■! t V. * : 0 '.J. VV.* -} \ . >'(
forms three different hydroperoxides (KLeinfeller, 1950).
There are many other examples to show that hydro¬
peroxides can be formed at saturated tertiary,
secondary and even primary carbon atoms of the hydro-
; carbons (for other references see Hawkins, 1961).
On the basis of these findings it seems that almost
any carbon atom in the cholesterol molecule is
potentially capable of forming a hydroperoxide by autox¬
idation. In fact a number of hydroxyiated derivatives
of cholesterol have been isolated as presumably products
of autoxidation (25- and 7a-hydroxycholesterols) (p. 4)
and as cholesterol 'companions' (24, 22 and 20-hydroxy-
-37-
cholesterols) (p. 3). The different bile acids and
their biosynthetic intermediates, the steroid hormones
and their intermediates, constitute a large number of
cholesterol derivatives, hydroxylated at different positions
of the molecule. In the degradation of cholesterol side-
chain to form bile acids and steroid hormones, 26-
hydroxy (Danielsson, 196le), 20-hydroxy (Shimizu,
Hayano, Gut and Dorfman, 1961; Constantopoulos and
Tchen, 1961) and 20, 22e-dihydroxy (Constantopoulos,
Satoh and Tchen, 1962; Shimizu, Gut and Dorfman,
1962) derivatives of cholesterol have been shown as
intermediates. This shows that almost all the carbon
atoms of the cholesterol side-chain can be hydroxylated,
though in different tissues. Similarly most of the carbon
atoms on the nucleus are also capable of hydroxylating,
the important centres known being C7, Ctl, C12, Cxj, C17
and sometimes the angular methyl at CXj.
Since, for most of these hydroxylations it has been
shown that the oxygen used is in a molecular state, it
would seem that the mechanism of these hydroxylations
is somewhat similar to that of the autoxidation reactions.
38-
Thus, by analogy with the known hydroperoxidation
reactions described above (autoxidations - photo¬
sensitized and catalysed) it seems that a hydroperoxidation
at any of the carbon atoms in cholesterol, can be
initiated by autoxidation with molecular oxygen. The
yield of the hydrocarbon-hydroperoxides produced by
autoxidations is low, nevertheless the reaction does
occur and in biological systems the same reactions
could be catalysed by the enzymes to give better
conversions. These hydroperoxides could then be
reduced to the respective hydroxylated derivatives by
reduction with a reducing enzyme such as TPNH which
has indeed been shown to be required for a number of
biological hydroxylations. Although most of the carbon
atoms in cholesterol could form hydroperoxides, some
of them seem to be very difficult to attack because of
stereo-electronic factors. Since the tertiary carbons
are known to be more reactive than the secondary or
primary, towards oxidation by different means.
Figure 81*1 S
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including autoxidation in air, it seems that the tertiary
carbon atoms 25, 20, 17, 14, 9 and 8 would probably be
the most susceptible to an attack by molecular oxygen.
Of all the tertiary carbon atoms in the cholesterol
molecule, the Cg (p-lydrogen) is sterically hindered
because of the two angular methyls (Ci0 and C13) in the
q
,
vicinity (see Figures 1 and iffli). Carbon atoms 9 and 14
(a -hydrogens) are near the very reactive centre at Cf,
A hydroxylation at that position (Gj) would be much
easier than at any of these positions and once the
position 7 has been attacked to form a hydroperoxide or
a hydroxyl, Cg and CJ4 are difficult to approach. Thus,
apart from C7, the most likely centres for an oxygen
attack are the carbons 25, 20 and 17. The carbons 20
and 17 have indeed been shown to be important in the
study of steroid hormones but the C85 has not been
studied so well. A hydroxylation at C25 could be one of
the stages in the cleavage of the cholesterol side-chain
in the formation of bile acids but its importance can not
be emphasized further because of the lack of
information about this reaction from biological systems.
-40-
Although the hypothesis that the steroid
hydroxylations may occur through hydroperoxide
intermediates sounds quite reasonable* it has little
experimental evidence to prove it. It would be of
interest to test different relevant hydroperoxides in
biological systems and see if they are converted into
the hydroxylated products and/or the end products.
-41-
In this introduction an attempt has been made to
show that in the degradation of cholesterol to bile acids
there may be a large number of intermediates involved.
The whole sequence of reactions involved in this
degradation is, however, not yet known. A number of
possible intermediates have been synthesized and used
for in vivo and in vitro studies but still there are a
large number of compounds which could be postulated as
intermediates but have not yet been synthesized - e, g.
i) The mechanism of the initial hydroxylation at
C7 is not known and the possible intermediates have not
been synthesized.
ii) The existing methods of synthesis of the inter¬
mediates involved in the epimerization of the hydroxyl
at C9 and saturation of the double bond are not very
i
effective (see p. 89).
iii) A number of other possible intermediates have
not been synthesized.
In this work an attempt has, therefore, been made
i) to synthesize the possible intermediates involved in
the 7a -hydroxylations;
-42-
ii) to devise improved methods of syntheses of the
intermediates involved in epimerization at C$ and
saturation of the double bond;
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ADSORPTION CHROMATOGRAPHY
Alumina and silicic acid have been used for the
column chromatography of most products. A number of
sterols, especially those carrying a 7a-hydroxyl
function in the quasi-axial position, have been found to
i give dehydration products if put on active alumina.
I
Several adsorption grades of alumina and silicic acid
were thus tried, the preparationsof which are described
below.
'Active' Alumina
Alumina (activated, type 'O') obtained from Peter
Spence was heated at 800* overnight and then allowed to
! cool slowly in the furnace to about ISO*. It was then
taken out and allowed to cool in a metal desiccator and
I
stored in tightly stoppered bottles.
I
'Neutral' Alumina
Five hundred grammes of 'active' alumina were
slurried with methanol and acidified with 3N-HC1 to
-44-
about pH 3. The methanol was poured o£f and the
alumina washed with water until the washings were
neutral. It was then dried at 100* for 24 hours and
stored.
'Deactivated' Alumina
The 'neutral' alumina was deactivated by adding a
certain amount of water to it; a few ml. of water were
added dropwise to the neutral alumina and mixed
thoroughly. The proportions of water added varied
for different preparations giving different grades of
deactivated alumina, described at appropriate places in
the text.
Silicic Acid
Two grades of silicic acid were used: ordinary
silicic acid (100 mesh powder, obtained from Mallinck-




Certain compounds which are unstable on alumina
or silicic acid columns were found to be quite staide on
thin-layer chromatograms. This fact led to the
preparation of deactivated silicic acid which has almost
the same activity as the silica gel on thin-layer.
Silicic acid was washed with water several times and




In recent years thin-layer chromatography
(Kirschner et al. 1951, 1952; Stahl, 1953) has become
a very useful tool in the separation of small amounts of
materials (for review see Demole, 1961). It has been
widely used for separation of small amounts of chemical
products of biological reactions, but its use in organic
chemistry has been rather limited. In the study of
steroids, this method of chromatography has been very
successful and is being widely used because of its
superiority over the tedious method of paper chromato¬
graphy. Thin-layer chromatograms are easy and quick
to prepare and take only about an hour to develop and so
thin-layer chromatography (TJLC) can be used in a
number of ways in the study of organic compounds.
This method of chromatography can be further
elaborated by the use of fluorescent thin-layer
chromatograms (Boyd and Hutton, 1963). This is a non¬
destructive method for ultraviolet light absorbing
materials which quench the fluorescence of the chromato-
-47-
gram under u. v. light source. The dark spots due to
the u.v. absorbing material can be eluted directly from
I
the plate.
A typical procedure used for this type of chromato¬
graphy used in this work is outlined below.
The thin-layer chromatogram is prepared, as
usual, by spreading over a glass plate a slurry of a
mixture of 5% zinc silicate in Kieselgel (Kieselgel G.
nach Stahl, Merck) in water. The plate is dried in the
I
I oven (100*) for 30 min. and then allowed to cool. The
substance to be chromatographed is spotted on to the
plate and the chromatogram developed in a suitable
solvent system by ascending chromatography (about
1 hr. was typical for developing an 8 inch chromatogram).
The plate is left at room temperature to evaporate the
solvent and is then viewed under an ultraviolet light
{ source and the u.v. absorbing materials, if any, are
marked and, if required, eluted for further investigations.
This method of chromatography has been used in a
number of different ways for the study of a number of
organic reactions described here.
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i) If the reaction is slow the reaction mixture can
be sampled out at suitable intervals and chromatographec
I
|
by TLiC. The product or products can be found out at
each time and the reaction can be stopped when the
whole of the starting material disappears or when it
I
seems to have reached an equilibrium. A number of
specific colouring reagents have been used as sprays
to develop coloured spots on the chromatogram. This
was the usual method used for following most of the
reactions described in this work. The details of
different solvent systems and the colouring agents used
are given at appropriate places.
ii) The purity of the compounds can be checked by
running thin-layer chromatograms in different solvent
systems; if the compound gives a single spot in all the
systems it is quite a good indication of its purity. The
same method can be applied for co-chromatography of a
known compound with an unknown. In this work TLC
has been used as one of the standard criteria of purity.
iii) This method was also used for checking
different eluates obtained from adsorption chromato¬
graphy on columns; each cut is concentrated and rim on
-49-
a thin-layer chromatogram and the ones having similar
spot or spots are pooled together. To check further
if one spot is due to one component, the pooled eluates
can be run in different solvent systems.
I
iv) Besides being used for following the reactions
: and checking purity of the compounds, this method also
gives some further information. During the follow-up
of a reaction mixture it can give information about the
number and some properties of the side-products;
their mobility on a certain solvent system can give an
idea about the polarity of the molecule, the formation of
certain products can be shown by using specific sprays.
The deficiencies of this method are that:
i) It is not quantitative.
ii) If there are a number of products formed it gives
little information about the mode of formation of these
products, whether they are a result of breakdown of
the desired product or are formed directly from the
I
starting material or are intermediates in the synthesis
of the desired product.
iii) The compounds which do not give a simple colour
reaction cannot be detected.
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These difficulties can be overcome and this method
can easily be made quantitative by using labelled
| substrates and coupling the TLC with radioactive
counting; the reaction mixture is applied on to the
chromatogram and it is then developed and cut into
sections and eluted. In actual experiments, two spots
i of the reaction mixture were put on to a plate, the
developed chromatogram was viewed under a u, v, light
source and the dark spots, if any, due to a u.v.
absorbing material were noted. One half of the
chromatogram was then sprayed with a suitable
I ■
colouring agent and the other half cut into eight parts
i (these cuts corresponded to spots and blank spaces of
and 27
, the chromatogram) (Fig, 25/) and eluted with suitable
I
i solvents (chloroform, chloroform-ethanol or ether-
ethanol). The solvents were evaporated and the
residue counted by liquid scintillation counting.
Besides being quantitative this method can give a
significant amount of other information about the
reaction. The advantages of this method are:
-51-
i) Very small amounts of the substrates can be
used and so it can even be used for fast reactions;
a pilot experiment can be done on a very small amount
and the time required for the reaction, the nature of
products formed, etc., can be obtained by this method
and then the reaction can be repeated with a larger
amount.
ii) Reaction rates can be found. If a sample of
the reaction mixture is chromatographed on TLC, the
total radioactivity applied is given by the total counts
from the plate and the proportion of different products
at a particular time can be calculated corresponding to
their respective radioactive counts.
iii) Whether the other products, besides the
desired one, are a result of the breakdown of the
desired product or are intermediates or side products
can be found out by the decrease in the radioactive
peak corresponding to the required product and
increase in the radioactivity of other products or vice
versa.
iv) The purity of labelled compounds can be
checked by running the chro - -" - - in different
-52-
solvent systems and counting; it should have all the
radioactivity accumulated in the cut corresponding to
the substance.
v) If the product of the reaction contains a u.v.
absorbing substance and a non-u. v. absorbing one
running with the same mobility in different solvent
systems, their relative amounts can be found out.
The u. v. absorbing spot can be eluted from the plate and
its optical density and thus its amount can be calculated,
I
the same eluate can be evaporated and counted. The
total count gives the count due to both constituents and
the count for individual compounds can thus be
calculated. An example of this could be in vitro studies
using labelled cholesterol as substrate. If there is
26~hydroxycholesterol formed it will be difficult to find
since it runs with the same mobility as 7-ketocholesterol
on different solvent systems. By this method this
problem can be resolved.
vi) The method can be used for kinetic studies of
steroid reactions. Since the main purpose of studies
undertaken in this work was the synthesis of possible
intermediates, kinetic interpretations to the results
have not been discussed.
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vii) The method can also be applied to compounds
which do not give a colour reaction on the plate.
For slow as well as fast reactions this method of
TL.C and counting can serve as a quantitative 'minute-
to-minute' account of the reaction. A number of
reactions have been studied by this method and the
results are outlined later. The main purpose of these
reaction studies was to find the time course for certain
reactions and so the results have not been given other
inte rpretations.
Radioactive Measurements
All radioactive measurements have been done by
liquid scintillation counting on Packard Tricarb liquid
scintillation counting system (model 314EX). The
scintillator used was 5 g. PPO (2, 5-diphenyloxazole,
scintillation grade; fluorescence max. 3800A) and
0.3 g. dimethyl POPOP (1, 4-bis-2-(4-methyl-5~phenyl-
oxazolyl)-benzene, scintillation grade; fluorescence
max. 4300A) in one litre of toluene; 10 ml. of this
scintillator solution were used for each count. When
-54-
the eluates from TLC were to be counted, the eluate
was taken into a counting vial and then evaporated;
10 ml. of the scintillator solution were added and the
solution counted.
Ultraviolet Spectroscopy
The u. v. absorption measurements were done on
spectrophotometer SP500 and the Optica recording
spectrophotometer. The substance was usually read
in an ethanol solution. For viewing fluorescent thin-
layer chromatograms a u.v. lamp (mercury lamp;
maximum emission 254 m,, ) was used.
Infrared Spectroscopy
The infrared absorption measurements were
carried out on an Infracord spectrophotometer
(Perkin-Elmer) using the KBr disc method. The discs
were prepared from 2 mg. samples of the compounds
in about 200 mg. of KBr (dry, anhydrous); the
compound was mixed with KBr under an infrared light
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source and the disc prepared by pressing the material
in a metal dye. A blank KBr disc was always used in
the reference beam.
All the infrared spectrograms are given in the
Appendix.
Radioactive Labelling
For the preparation of most of the labelled
compounds, tritium was used as the labelling isotope.
The labelling was done by the Wilzbach method
(Wilzbach, 1957). It was found that longer exposures
of the steroid with tritium led to several artifacts.
The compounds were thus left in contact with tritium
for a shorter time. For most of the labelled compounds
72 hr. were found sufficient to give a compound of
reasonably high specific activity. By using the method
of shorter exposure time the number of artifacts was
reduced considerably and the purification of the
products was found much easier and the yields were
better. After 72 hr. the pressure was released and
the unused tritium diluted with compressed air and
allowed to escape through a fume cupboard. The
product was dissolved in a hydroxylic solvent like
methanol and the solvent evaporated. The process
was repeated several times to remove the labile*
tritium. The labelling of certain compounds and
further purification of the products is described later.
All radioactive compounds were stored in benzene
at the deepfreeze temperature.
Melting Points and Optical Rotations
All melting points have been determined on a
Kofler micro-stage (microscope RCH) and the optical
rotations on Hilger polarimeter M412. All the [a] -q
values given are for an approximately 2% solution of




The photosensitized oxygenation reactions are well
known but their use in syntheses has been rather limited.
In these reactions the choice of solvent, the concentration
of the substrate, the selection of a sensitizing dye and
the form of the light source seem to be of a considerable
importance.
Solvents
The photosensitized oxygenations have been con¬
ducted in different solvents (pyridine, benzene, alcohols,
chloroform, etc.), the most widely used being pyridine
and chloroform. If the oxygenations of steroids with a
5, 6-double bond are conducted in chloroform solution,
the hydroperoxide group is introduced stereo-
specifically at the allylic 7a-position (Schenck,
Gollnick and Neumuller, 1958b) without shifting the
double bond, while with most other solvents the
hydroperoxidation occurs at unsaturated tertiary
carbon atom at position 5 with a subsequent allylic
shift of the double bond into the 6, 7-position. The 5a-
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hydroperoxide, cholest-5~en-3{3-ol-5a -hydroperoxide
(Schenck £t al. 1957), is stable as a crystalline solid
and also in pyridine solution but when left in suspension
in chloroform or dioxan it undergoes rearrangement to
form cholest-5-en-3f3-ol-7a-hydroperoxide (Schenck,
Gollinck and Neumuller, 1958 a; Lythgoe and Trippet,
1959).
The choice of the solvent, thus, depends on the
desired mode of attack on the substrate (5a or 7a) and
also on the solubility of the substrate and the photo¬
sensitizing agent. Since for this work 7a-peroxidation
was the primary aim, most of the photo-oxygenations
were conducted in chloroform solution.
The concentration of the substrate in the solvent
is important since in dilute solutions in presence of a
sensitizing agent the mode of oxygen attack is more
specific and there are fewer breakdown products so
the solutions used were quite dilute. In most of the
reactions described later there was no trace of an
ultraviolet absorbing material showing absence of any
7-keto compounds. Nevertheless, there were always
some 7a-hydroxylated compounds formed by the break¬
down of the hydroperoxide.
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All the substrates used in the described photo-
oxygenations are very soluble in chloroform but most
of the dyes used as sensitizers in previous photo-
oxygenations are not very soluble in chloroform.
A new catalyst, haematoporphyrin methyl ester, was
thus developed for these reactions.
Catalysts (Sensitizing Dyes)
A large number of synthetic and natural dyes have
been used as sensitizing agents for the photo-oxygenation
reactions (Schenck et al. 1958; Oster etal. 1959;
Livingstone and Owens, 1956). It has been shown that
only dyes capable of photo-reduction can act as
sensitizers and that the quantum yield of the reaction
decreases markedly with the increasing dye
concentrations (Oster £t al. 1959). There are some
dyes which act within 5 min. of the start of the
oxygenation while some others take about 20 min.
Since for most of the photo-oxygenations described
here, chloroform was the solvent (for reasons discussed
elsewhere) only such dyes were chosen which are very
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soluble in chloroform. For oxygenations where
pyridine was used as the solvent haematoporphyrin,
rose bengal, eosin, and protoporphyrin were used as
photo-sensitizers but when the reaction was conducted
in chloroform, haematoporphyrin methyl ester was
used.
This new catalyst has been prepared from haemato
porphyrin by different methylation procedures;
methanolic HC1, dimethoxypropane and boron tri-
fluoride-methanol complex have been used as methyl-
ating agents.
Light Source
Different light sources were tried.
Fluorescent lamps (Phillips TL AD, 15 w, 18M long),
Tungsten filament lamps 8M long), Rubidium lamp
(8M) and a HgZnCd lamp (Phillips, Holland; type
93145E), all gave the hydroperoxide but the
fluorescent lamps were found to be the most
satisfactory. With this lamp the temperature of the
reaction mixture does not go above 20° C, while with
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Tungsten filament lamps and the mercury-zinc-
cadmium lamp, the temperature was high and so there
were more side reactions. In all the experiments
described two or four 15 watt fluorescent lamps were
used.
The mercury-zinc-cadmium lamp was chosen
because it has emission maxima in the same regions as
the absorption maxima of haematoporphyrin methyl
ester. But this lamp gave a high temperature, and so
a number of breakdown products; though this lamp
seems to be much more effective since all the starting
material was used up within 5 hr. of the reaction
while with other lamps it took a longer time. It seems
possible to control the temperature by either water
jacketing the reaction tube or passing dry cold air
through the space between the light source and the
reaction tube, but since the other lamps gave









Different reaction tubes were devised as to suit
the volume of the solvent and the type of the light
source used (Fig.10). With a single 70 w
fluorescent lamp. Rubidium lamp and Hg. Zn, Cd. lamp
the reaction tube was a tube-within-a-tube type of
cylinder with the light source inside, while for other
lamps a straight tube was used. In both types of
reaction tube, the oxygen was admitted via a sintered
disc at the bottom of the tube.
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A typical method of photo-oxygenation and the
following up of the reaction procedures is outlined
below.
The steroid was dissolved in the solvent and the
appropriate amount of the catalyst added. The
solution was poured into the reaction tube (one of the
types already described) and photo-oxygenated with a
smooth stream of oxygen from a cylinder,the light
source being one of the lamps described. (It was
sometimes difficult to keep the volume of the solvent
constant because of losses through evaporation. The
volume was usually made up every hour by adding some
fresh solvent.) The reaction mixture was tested every
2 hr. by taking out a sample and running on a thin-
layer chromatogram. Two spots of the sample were
put on a fluorescent thin-layer chromatoplate and run
in a suitable solvent system. After drying and viewing
under a u.v. lamp, one half of the plate was sprayed
with potassium iodide (10% solution in ethanol-water
4:1 with a few drops of acetic acid); the hydroperoxide
liberates iodine and a pale yellow colour develops
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which deepens later. The other half of the plate was
sprayed with phosphotungstic acid (PTA) which gives
a bright pink colour to the hydroperoxides and different
colours to the starting material and the breakdown
products like the hydroxy compounds or the ketones.
The reaction was stopped after a suitable time and
the product worked up as described under different
preparations.
SECTION HI
SYNTHESIS OF 7a-HYDROXYLATED COMPOUNDS
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Introduction
As discussed earlier (p. 12 ) the 7a-hydroxylation
seems to be one of the early stages in the degradation of
cholesterol to bile acids and there is a possibility that
this hydroxylation is brought about through hydroperoxide
intermediates {p. 34 and p. 39). In such a
case cholest-5-en-3|3-ol-7a-hydroperoxide and cholest-
5-en-3p, 7a-diol would be intermediates.
It has been shown that cholest-5-en-3£, 26-diol can
be efficiently converted into chenodeoxycholic acid in the
bile fistula rat. and in vitro it can hydroxylate at Cy to
give cholest-5-en-3£, 7a, 26-triol. If this 7a-
hydroxylation also proceeds by the same mechanism, viz.
the reduction of a hydroperoxide intermediate, then
cholest-5-en-3j3, 26-diol-7a-hydroperoxide would be an
intermediate.
Photo-sensitized oxygenations have been used for the
preparation of hydroperoxides. It has been shown
(Schenck et al. 1958) that if the reactions are carried out
in chloroform solution, the 5-6-unsaturated steroids
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form the hydroperoxide in the allylic position 7; the
oxygen attack is from the rear and thus results in the
formation of 7a-hydroperoxides. This method of 7a-
hydroxylation has great promise in the syntheses of 7a-
hydroxylated derivatives of A®-steroids. Since the
oxygen attack in this method is very specific at the allylic
7a-position, a number of A9-steroids having hydroxyl
groups elsewhere in the molecule can be hydroxylated at
CT without protecting the hydroxyls. A large number of
cholesterol metabolites can thus be synthesized by this
method.
In this work the photo-oxygenation reactions have been
used to synthesize some 7a-hydroperoxy and 7a-hydroxy
compounds which are possible intermediates in
cholesterol degradation. Cholesterol and cholest-5-en-
3(3, 26-diol have been used to prepare the respective 7a-
hydroperoxides and the 7a -hydroxy derivatives. The
cholest-5-en-3(3, 26-diol-7a-hydroperoxide was not
isolated from the reaction mixture; the crude product was
directly reduced by potassium iodide or sodium borohydride
to give the cholest-5-en-3(3, 7a, 26-triol which was isolated
by chromatography.
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It has been shown (Sehenck et al. 1958) that if the
photo-oxygenation is conducted in pyridine solution the
product is a 5a -hydroperoxide which if left in suspension
in chloroform rearranges to the 7a -hydroperoxide.
Choiest-5-en-3[3-ol-7a-hydroperoxide has been
synthesized by two methods, viz. the isomerization of
the 5a-hydroperoxide and by the direct photo-oxygenation
of cholesterol in chloroform solution.
Preliminary experiments have been done on the
photo-oxygenation of methyl 3p -hydroxy-5-cholenate in
chloroform and the production of the hydroperoxide has
been shown by liberation of iodine. The crude hydro¬
peroxide was reduced with borohydride to give the
corresponding hydroxy compound. The reduction
product showed two spots corresponding, possibly, to
the 7a- and 7p-hydroxylated derivatives and the
separation of the two isomers could not be effected by
chromatography or repeated crystallisation.
A quantitative study of the time course for the
photo-oxygenation reaction using cholesterol as the
model compound has been undertaken by using C14-
labelled cholesterol (Fig, 11 and 12)» The photo-
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oxygenation was carried out as described previously
(p. )» following the reaction by TLC.
Each chromatogram was cut into sections, eluted
and counted. After 4 hours of the reaction about 22%
of the total radioactivity was found in the cut
corresponding to the hydroperoxide and the rest was in
the cholesterol cut. The amount of the hydroperoxide
increased during the Erst 16 hours and the amount of
cholesterol decreased correspondingly. After 16 hours,
however, a new product emerged having a mobility like
that of the 7a-hydroxycholesterol and the relative
amounts of the cholesterol and the hydroperoxide
decreased. That this new product is probably the 7a -
hydroxycholesterol is further indicated by its colour
reaction with phosphotungstic acid (a blue colour) and a
Lifschutz test. This product kept on increasing while
the amounts of cholesterol and the hydroperoxide
decreased over another 16 hours. This indicates that
this product is being formed from the hydroperoxide and
could very well be the 7a-hydroxycholesterol.
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At 24 hours a new product Rjp 0. 72 giving a
blue colour with pbosphotungstic acid (PTA) appeared
while the amounts of cholesterol* the hydroperoxide
and the hydroxy compound all decreased. This seems
to be a product formed from the 7a -hydroxycholesterol
either by dehydration or some other reaction which
removes or blocks one hydroxyl. The product is non-
u. v. absorbing, has a mobility which suggests one
nuclear hydroxyl and one other non-polar substituent
(since its mobility is slightly less than cholesterol
itself), it gives a blue colour with PTA. This product
was not isolated for any further investigations.
From the above experiment it appears that under
these conditions the production of the hydroperoxide
goes steadily up during the first 16 hours and then it
starts decomposing into other products. Thus 16 hours
was taken as the standard time for this reaction.
The oxygenation was kept on for 60 hours at the end of
which there were a number of other u.v. absorbing and
non-u. v. absorbing products formed. The whole plate
was full of spots all having radioactivity (Fig. lJ8»and 11).
I
It was not worked up to isolate any compounds.
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Such experiments when repeated using four 15 w
fluorescent lamps showed the same type of curves but
the reaction was faster and the amount of the 7a -
hydroperoxide reached its peak after 5 hours.
Cholest-5-en-3p, 7a-diol has been prepared by a
photo-oxygenation of cholesterol and the subsequent
reduction of the hydroperoxide. The existing method
of synthesis of this compound by an ailylic bromination
(Henbest and Jones, 1948) does not give good yields and
the 3{3-hydroxyl has to be protected while in the photo-
oxygenation method the hydroxyl need not be protected.
This latter method can, thus, be used for 7a-
hydroxylation of compounds having other hydroxyls in
the molecule. Different methods have been used for the
reduction of the hydroperoxide. The reduction with .K1
or with metal hydrides gave the same results. In
every experiment there was, invariably, a trace of 7p-
hydroxy compound formed which could be separated by
crystallisation of the product. Since there was no
trace of a u.v. absorbing material in the original
photo-oxygenation product, the presence of the 7p-
compound suggests that there is some 7p-hydroperoxide
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formed in the photo-oxygenation reactions which gives
the 7p-hydroxy product. That the compound is not the
5a -hydroxy! derivative, which could have been produced
by the reduction of 5a -hydroperoxide in the photo -
oxygenation product, is shown by co-chromatography of
the product with an authentic sample of cholest-6-en-
3j3, 5a~dioi; the 3fJ, 5a -diol has a different Rp from
that of the 3f, 7^-diol, The product obtained here has
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STUDY OF THE TIME COURSE OF THE PHOTO-
OXYGENATION REACTION OF CHOLESTEROL
To study the reaction rates of these photo*
oxygenations 14C-labelled cholesterol was used and the
reaction followed by thin-layer chromatography coupled
with liquid scintillation counting (p. 63).
I4C-Labelled Cholesterol
. The i4C-Iabeiled cholesterol was obtained from rats
given l4Cj-mevalonate. This sample of cholesterol was
run on a thin-layer chromatoplate (benzene:ethyl acetate
Zil); two spots were put on one plate and after
developing the chromatogram one half of the plate was
sprayed with PTA which showed a spot corresponding to
cholesterol and traces of some more polar material.
The other half of the chromatogram was cut into eight
sections and the sections eluted separately and counted.
All activity was found in the cut corresponding to
cholesterol. To remove the more polar material
(though not radioactive) the crude product was









type "O'). Elution with 50% and then 60% ether in
benzene gave pure cholesterol (single spot on TLG and
one radioactive peak); m. p. = 146*; specific activity =
22, 225 c, p. m. /mg.
Photo-Oxygenation of |4G-Cholesterol
WC-Labelled cholesterol (50 mg.) and 15 mg.
haematoporphyrin methyl ester in 50 ml. chloroform
were photo-oxygenated for 60 hours. A sample was
taken out every 4 hours and two spots put on a
fluorescent thin-layer chromatoplate. After
developing the chromatogram (benzene:ethyl acetate
2:1) one half of the plate was sprayed with PTA while
the other half cut into eight sections, eluted and counted
as usual (pp. 50 & 63). The total count on the chromato¬
gram and the count corresponding to different spots on
the plate gave the respective percentages of the
starting material and the different products. The
results are summarized in the form of a graph (Fig. 12).
At the end of the reaction the product was not worked up.
The thin-layer chromatograms developed at different
stages of the reaction are shown in Fig. 11.






Cholesterol (5.0 g.) and 40 mg. of haemato-
■ ' '
; . .
porphyrin were dissolved in 100 ml. of pyridine and
photo-oxygenated for 20 hours. Evaporation of the
solvent and crystallization of the residue from methanol
left the photo-sensitizer dye in the supernatant. Two
more crystallizations gave a colourless crystalline
product.
m.p. - 141* C & H Theory Found
* +35 C = 77.51% 77.29 %
IR (}>) = see Appendix H= 11.00 % 11.05 %
Fig. 1
The experiment was repeated using eosin and also
rose bengal as catalysts and it gave identical results.
Cholest- 5- en- 3{3-ol-7a -hydroperoxide
1) By isomerization of cholest-6-en-3p-ol-5a-
hydroperoxide
Cholest-6-en-3p-ol-5a-hydroperoxide (500 mg.)
was left in suspension in pure dry chloroform obtained
by filtration of the ordinary solvent through active
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alumina. When ordinary chloroform was used the
product showed several spots on TL.C. After 12 hours
the solution was evaporated to dryness under vacuum
and the residue crystallized from benzene. Thin-
layer chromatography (benzene:ethyl acetate 2:1)
showed a trace of some more polar product which
stained blue with phosphotungstic acid and had an Rjr
(0.2) like 7a -hydroxycholesterol. Repeated
crystallization from benzene, methanol, petroleum
ether-ethyl acetate or ether-ethyl acetate could not
improve the product. The dry crystals were dissolved
'
in 15% ether in petroleum ether (100 ml.) and
chromatographed on 'deactivated* silicic acid (washed
with water and dried at 100* overnight). Elution with
500 ml. of 30% ether in petroleum ether (60-80) gave
the hydroperoxide shown by one spot on TLC and
liberation of I2. Evaporation of the eluates and
crystallization of the solid product from benzene gave
350 mg. of pure cholest-5-en-3£ ol-7a -hydroperoxide.
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C & H Theory Found
m.p. = 147* C = 77.45% 77.27%
[ojg = -135 H= 11.08% 10.96%
IR (V) = Appendix Fig. 2
ii) By direct photo-oxygenation of cholesterol
Cholesterol (4 g.) and haematoporphyrin methyl
ester (40 mg.) were dissolved in chloroform (100 ml.)
and photo-oxygenated (two 15 w fluorescent lamps);
the reaction was followed by TEC as usual. After 20
hours the reaction was stopped and the solvent
evaporated. The residue was dried and chromatographed
on silicic acid as before. Elution with 20% and 25%
ether in petroleum ether (60-80) gave the starting
cholesterol and the hydroperoxide was eluted with 30%
ether in petroleum ether. Evaporation of these
eluates and crystallization of the residue from benzene
gave pure cholest-5-en-3p-ol-7a-hydroperoxide.




IR ())) = see Appendix Fig. 4 2/
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Tritium labelled cholest-5-en-3{5-ol-7a -hydroperoxide
Cholest-5-en-3|3-ol-7a -hydroxperoxide (50 mg.)
was left in contact with tritium in the Wilzbach apparatus
(as described on p. 54 ) for 48 hours. The 'labile1
tritium was removed in the usual way (p. 54 ) and a
sample of the product checked on thin-layer; the thin-
layer chromatogram was cut into sections, eluted and
counted. The chromatogram showed two radioactive
peaks, one major corresponding to the hydroperoxide
and the other more polar. The product was chromato-
graphed on 'deactivated' silicic acid (10 g.). The
column was first washed with 15% ether in petroleum
ether and the hydroperoxide eluted with 30% ether in
petroleum ether (60-80) (200 ml.). Evaporation of the
eluates and crystallization of the residue from benzene
gave labelled cholest-5-en-3p-ol~7a-hydroperoxide
shown by TEC and counting to be pure (one radioactive
peak).
m. p. = 149*
Specific activity = 450, 000 c. p. m. /mg.
(counter efficiency = 40%)
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Cholest-5-en-3{3, 7a,-diol
i) From cholest-5-en*3p-ol-7a -hydroperoxide
a) By reduction with potassium iodide
Cholest-5-en-3f3-ol-7a-hydroperoxide (500 mg,)
was dissolved in 60 ml. of ether-ethanol (1:5) and
potassium iodide(2. 5 g.) and acetic acid (3 drops)
added and the salt dissolved by shaking. The mixture was
then refluxed gently for 30 minutes. The solvent was
evaporated, the product extracted with ether, washed
with sodium thiosulphate (until colourless) and then with
water. The dried ether extract was evaporated and the
residue crystallized from methanol to give colourless
crystals of cholest-5-en-3p, 7a-diol (400 mg.).
m. p. = 187* C27H4602 requires C = 8.0.59%
H = 11.4%
Ial n = "92 Found C = go-1 %
'
H = 11*02, %
b) By reduction with lithium aluminium hydride
Cholest-5-en-3p-ol-7a-hydroperoxide (200 mg.)
was dissolved in 5 ml. of ether and added dropwise to
250 mg, of lithium aluminium hydride. The tube
containing the steroid was washed with another 5 ml. of
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ether and added to the reaction flask and the mixture
refluxed for 20 minutes. The excess of the reagent was
destroyed with 20 ml. of ether-ethyl acetate (2:1) and
the product poured into a saturated solution of sodium
potassium tartarate and extracted with ether. The
ether extracts were washed, dried and evaporated and
the residue crystallized from methanol to give 120 mg.
of crystals.
m. p. = 188°
tdixed m-f. ®
ii) From bromination method
The cholest-5-en-3(3, 7a-diol obtained by the above
two methods was compared with an authentic sample
prepared by the allylic bromination method of Henbest
and Jones (1948).
The modified method of allylic bromination and
hydrolysis was as follows.
Cholesterol acetate (1.0 g.) was refluxed with
0. 50 g. of N-bromosuccinimide in petroleum ether
(60-66*) under light - the light and heat provided from
two 150 w photoflood bulbs (2® away from the flask).
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The product was filtered and the filtrate evaporated to
dryness. Repeated crystallization from acetone gave
the 7a -bromo-cholest-5-en-3|3-acetate.
Cholest-5-en~7a ~bromo-3p-ol-acetate (0. 30 g.)
was taken up in 2 ml. ether and treated with 0. 30 g. of
sodium formate in 3 ml. of formic acid at room
temperature overnight. The product was extracted with
ether, evaporated, and the residue hydrolysed by
refluxing with sodium ethoxide in ethanol for 1 hour.
The product was diluted with water, acidified, and
extracted with ether. Evaporation of the dried extract
and chromatography of the residue (230 mg.) on neutral
alumina (10 g.) gave 7-hydroxycholesterol.
The eluates containing the diol (5% and 10%
methanol in ether) showed a trace of some slightly less
polar component R^ o. 42 (presumably 7§-hydroxy-
cholesterol), in addition to the spot corresponding to
7a-hydroxycholesterol R-p0.35(TLC solvent system
benzene:ethyl acetateracetone, 10:5:3).
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To remove this material the product was
acetylated by refluxing in acetic anhydride and the
diacetates chromatographed on neutral alumina (10 g.).
Ten percent and then 20% benzene in petroleum ether
eluted the less polar compound,and 30% benzene in
petroleum ether and then benzene eluted the 7o -
compound cholest-5-en-3£, 7a -diol-diacetate.
Evaporation of these eluates and crystallization from
methanol gave 3a, 7a-dihydroxycholesterol diacetate ^
colourless crystals.
The diacetate was hydrolysed with methanolic KOH
at room temperature overnight. The product was
extracted with ether* washed and dried. Evaporation
of the extracts and crystallization of the residue from
methanol gave colourless crystals.
m. p. = 187*
Ho = -«
IR ( ) = See Appendix Fig, 3
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Cholest-5-en-3{5, 7a, 26-triol
i) By photo-oxygenation of cholest-5-en-3(3, 26-diol
and the subsequent reduction of the 7a-hydroperoxide
Cholest-5-en-3j3, 26-diol (250 mg.) was dissolved in
chloroform (75 ml.) and 21 mg. of haematoporphyrin
methyl ester added and the solution photo-oxygenated
(four 15 w fluorescent lamps). The reaction was
followed by TLC as usual. At the end of 6 hours the
reaction was stopped and the solution treated with 1 g. of
activated charcoal and filtered and the solid washed with
25 ml. of warm chloroform. The filtrate was
evaporated under vacuum and the residue, crude
cholest-5-en-3(3, 26-diol-7o -hydroperoxide, reduced
with KL or LiAlH4.
Reduction with KL
The residue was reduced with 1.0 g. of K1
in 25 ml, 1:5 ether-alcohol and the product worked up
as usual. The residue obtained from the ether extracts
showed several spots, on TLC, corresponding to the
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starting diol and the two triols, cholest-5-en-3P» 7a, 26-
triol and the isomeric 7p-compound. There were
traces of several other less polar products. The
residue was dried and chromatographed on alumina
(Peter Spence, active type 'O'). Five percent
ethanol in ether eluted the unchanged starting diol.
The triols were eluted with 30% and then 50% ethanol
in ether. The two eluates showed two spots, one
bigger and a trace of the other, on TLG (Rp 0. 2 and
0.15) (system • benzene:ethylacetate:acetone, 10:5:3)
corresponding to the two isomeric triols. These
eluates were evaporated and the residue crystallized
from ethyl acetate. Several crystallizations from ethyl
acetate gave a pure sample in the form of needles.
Thin-layer chromatography showed only one spot.
m. p. » 232*
IR(^ ) a See Appendix Fig. 4
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In this photo-oxygenation although there were
several other products produced, there was no trace of
any u.v. absorbing material. TLC on fluorescent
plates every 4 hours during the reaction did not show
even a trace of u.v. absorbing material.
ii) Reduction with lithium aluminium hydride
In another run with 200 mg. of 26-hydroxy-
cholesterol, the residue obtained after the removal of
the catalyst was reduced with 150 mg. LiAlSl* and
the product worked up as usual. Chromatography and
then repeated crystallization gave the cholest-5-en-
3J3, 7a, 26-triol.
m. p. = 232°
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k) By photo-oxygenation of cholest-5-en-3(3, 26-diacetate
Diacetate (200 mg.) and 15 mg, of haematoporphyrin
methyl ester in 75 ml. of chloroform were photo-
oxygenated as usual (solvent system for TLC,
benzene:petroleum ether:ethyl acetate, 40:60:6).
For the removal of the catalyst the reaction mixture was
taken into a flask and petroleum ether (60i80) was
added to make chloroform-petroleum ether (1:2). The
solution was filtered through deactivated silicic acid
and eluted with more chloroform-petroleum ether (1:2).
The eluates were evaporated and the residue reduced
with 200 mg. jLiAlH* in 15 ml. of ether. The product
was worked up as usual and crystallized from ethyl
acetate. Repeated crystallization with ethyl acetate
gave the triol which gave a single spot on TLC.
m. p. = 232*
IR ( V ) = See Appendix Fig. 4
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Attempted photo-oxygenation of 3p-hydroxy-chol-5-enate
Methyl-3(3-hydroxy-5-cholenate (300 mg.) was
dissolved in chloroform (100 ml.) and haematoporphyrin
methyl ester (30 mg.) added and the mixture photo-
oxygenated (four 15 watt fluorescent lamps). TLC
(benzene:ethyl acetate. 2:1) at every hour showed the
presence of a hydroperoxide (liberation of from Kl)
and a more polar material presumably the 7a-hydroxyl-
ated derivative , since it gave blue colour with phospho-
tungstic acid. The oxygenation was stopped after 6
hours, the catalyst was removed by treatment with char¬
coal and the clear solution evaporated, dried and the
dried residue reduced with potassium iodide. The
product showed several spots on thin-layer chromato¬
graphy; the main spot gave a blue colour with phospho-
tungstic acid and had a mobility (on TLC) which
suggested that it had two nuclear hydroxyl groups. This




Thin-layer chromatography has been used for
following a number of the steroid reactions described.
The procedure of fluorescent TLC/scintillation counting
developed in this work has been used in the study of
photo-oxygenation reactions.
A method has been described which can be used for
the synthesis of a number of 7a-hydroxylated A5-steroids.
Cholest-5-en-3p, 7a -diol has been synthesized through
the 7a -hydroperoxy intermediate using this method of
7a-hydroxylation by photo-sensitized oxygenation.
It has been shown that it is possible to use this
method for the 7a -hydroxylation of compounds having
other hydroxyl or ester groups in the molecule.
Cholest-5-en-3p, 7a, 26-triol has been synthesized and it
has been shown that 3p, 7a-dihydroxy-chol-5-enic acid




STUDIES ON POSSIBLE INTERMEDIATES
INVOLVED IN THE INVERSION OF
CONFIGURATION AT Ca AND THE
SATURATION OF THE DOUBLE BOND
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Introduction
Cholest-4-en-3-one-7a -ol, coprostan-3-one-7a -ol
and coprostan-3a, 7a-diol have been shown to be
possible intermediates in the degradation of cholesterol
to bile acids (p. 13). it has been shown that in the
conversion of cholest-4-en-3-one-7a -ol to coprostan-
3a, 7a -diol, cholest-4-en-3a, 7a -diol is another
possible intermediate (p. 17).
Goprostan-3-one-7a-ol was first synthesized by
Yamasaki et al. (1959a). While this work was in
progress, Danielsson (1961b) published a new method
of synthesis of this compound and a synthesis of
cholest-4-en-3-one-7a-ol (Danielsson, 1961a).
Cholest-4-en-3a, 7a-diol has not been described before
while coprostan-3a, 7a-diol has been synthesized
through a Kolbe's synthesis by electrolytic coupling of
chenodeoxycholic acid with isovaleric acid (Bergstrom
and Krabisch, 1957).
In the work described here all these compounds have
been synthesized by new and easier methods.
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The method of synthesis of cholest-4-en-3~one-7a -
ol described by Daniels son involves many stages and
the overall yield was very low. He claims 4-5%
yield of the product cholest-4-en-3-one-7a-olf from
3p-benzoxy-7a -tetrahydro-2'-pyranyloxy-cholesterol.
This latter compound has been prepared from 7a -
hydroxycholesterol benzoate which was, in turn,
prepared from cholesterol.
In the work described here, cholest-4-en-3-one-
7a -ol has been prepared by a four stage synthesis from
cholesterol giving an overall yield of about 13%.
Cholesterol was oxidized by an Oppenauer oxidation to
the cholest-4, 6-diene-3-one (Nickon and Bagli, 1961).
This diene-one was treated with monoperphthalic acid
in ether to get cholest-4-en-3-one- 6a, 7a-epoxide
(Nickon and Bagli, 1961). Attempts at selective
cleavage of the epoxide ring to the 7a-hydroxy compound
failed because of the vulnerability of the 3-keto group
to such reagents. The epoxide was thus reduced with
COPROSTAN - 3- ONE-7 «-OL
HC I ^ OH
COPROSTAN- 3 oc.7«e-DIOL
SYNTHESIS OF SOME DEGRADATION PROOUCTS OF CHOLESTEROL
Figure 14
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lithium aluminium hydride in tetrahydrofuran which
gave a mixture of cholest-4-en-3a, 7a -diol and
cholest-4-en-3p, 7a -diol. This mixture was re-
. -
oxidized selectively at the allylic position (Cj) using
manganese dioxide (Sondheimer et al. 1933).
Qppenauer Oxidation of Cholesterol
Cholesterol was oxidized to cholest-4, 6-diene-3-
one by an Oppenauer oxidation as used by Nickon and
Bagli (1961). The separation of this compound from
the reaction mixture was effected by chromatography on
active alumina. Separation was not possible when
ordinary alumina was used.
Epoxidation of Cholest-4, 6-diene-3-one
The cholest-4, 6-diene-3-one was treated with
monoperphthalic acid in ether to get the epoxide,
cholest-4-en-3-one-6a, 7a-epoxide. This epoxide was
found to be very sensitive to active alumina; when a
mixture of the diene-one and the epoxide, containing
known amounts of both (calculated from the respective
-91-
u. v. absorption peaks at 284 mp and 241 mp) was
chromatographed on active alumina, the amount of the
diene-one isolated from the eluates was about 30%
more than the amount originally put on. The amount
of the epoxide had correspondingly decreased.
A new grade of deactivated alumina (p. 44) was
then developed and the separation of the starting diene-
one and the isolation of pure cholest-4-en-3-one-6a , 7a -
. .
epoxide effected by chromatography of the mixture on
this alumina.
The epoxidation was carried out using mono-
perphthalic acid since perbenzoic acid did not give good
results (cf. Nickon and Bagli, 1961). To establish the
right conditions for this reaction the conditions were
varied and it was found that the reaction went better in
an excess of the per acid in dilute solution. These
experiments were done on quite small amounts of the
cholest-4, 6-diene-3-one and the amounts of the
products calculated from ultraviolet spectrophotometric
determinations; the optical density at 284 mp and
241 mp was measured and the respective amounts
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calculated (cholest-4, 6-diene-3-one, = 29# 000;
cholest-4-en-3-one-6a , 7a-epoxide# = 16# 000),
No effort was made to isolate the compounds.
Care must be taken using an oxidizing agent as
powerful as monoperphthalic acid and so it was
essential to investigate the best conditions for the
specific attack on the A**bond to the 6a, 7a - epoxide
with the minimum side reactions.
Thus a procedure was developed to study the
rates of this reaction at different temperatures. The
procedure for these studies is outlined on p. 102
and the results given in the form of a graph (Fig, 18).
On the basis of these findings, future experiments
were conducted with an excess of per acid in a dilute
solution and at 37* C. The wor-c-up procedure and the



























a. metal-hydride reduction of the epoxide b. some purified compounds
Figure 15
B.
1* Choiest*4-en-3a -ol-6a, 7a-epoxide.
2. Cholest-4-en-3a , 7a -diol.




Reduction of the Epoxide
The reductive cleavage of epoxide rings gives trans-
diaxial substituted products (Barton, 1953; see also
Fieser and Fieser, 1959) and the reduction of steroid
A4-3-ketone gives a mixture of 3a* and 3p-hydroxylated
compounds (McKennis and Gaffney, 1948; Plattner et al.
1948). Thus cholest*4* en*3-one-6a, 7a - epoxide would
be expected to give a mixture of cholest-4-en-3a, 7a -diol
and cholest-4-en-3p, 7a -diol if reduced with metal
hydrides. However, potassium borohydride and sodium
; . . . . »w * ■'
. • • • •! '' " "
borohydride seem to reduce the 3*keto group in
preference to the epoxide ring. Thin-layer chromato¬
graphy of the product of reduction of the epoxide with
these borohydride reagents showed several spots
corresponding to the unchanged epoxide, the two
expected diols and two products which were more polar
than the epoxide and less polar than the diols. Their
mobility (Rp = 0.53 in benzene:ethyl acetate (2:1)
system) suggested (Fig. 15) the presence of one
nuclear hydroxyl group along with a group like the
-94-
epoxide. At reduced temperatures the selectivity of
these reducing reagents increases (Fig. 15) and the
amount of the products corresponding to the diols
decreases (Fig. 15). Potassium borohydride actually
appeared to be more selective than sodium borohydride
(Fig. 15).
The epoxide when reduced with potassium borohydrid
in methanol at -5* gave a product whose properties
suggested it to be cholest-4-en-3a-ol-6a, 7o-epoxide.
The procedure for the synthesis of this compound is
described later (p. 106) and the proof for its
structure discussed in Section VI.
In the reduction with these metal hydride reagents
the 3a-isomer seems to be the predominant of the two
isomers 3a-ol and 3{3-ol. This selectivity seems to
decrease from potassium borohydride to sodium boro¬
hydride and lithium aluminium hydride, the last being
the least stereo-selective.
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Since borohydride reagents gave a mixture of
products and the reduction was not complete, the
cholest-4-en-3-one-6a, 7a-epoxide was reduced with
lithium aluminium hydride in tetrahydrofuran which
gave as the product a mixture of cholest-4-en-3a, 7a-
diol and cholest-4-en-3j3, 7a-diol which was used for
the next stage of the synthesis.
Since these reductions give the 3a-isomer as the
predominant of the two products, it is much easier to
remove the 3p-isomer either by repeated crystallization
or more easily by treatment with digitonin. A little of
the mixture of the diols was treated with digitonin and
cholest-4-en-3a, 7a -diol isolated. This compound has
not been described before.
Reoxidation of the Mixture of Diols
Manganese dioxide has been found to be a selective
oxidizing agent for allylic hydroxyl groups (Sondheimer
et al. 1953). The mixture of the diols obtained by the
reduction of the epoxide was oxidized with manganese
dioxide in chloroform. To study the effect of




up, one at room temperature and the other at 50*.
The one at 50* showed that the amount of the product
started decreasing after 2 hours and after 3 hours it
showed a trace of material absorbing at 284 mp
(Fig. 16) but when conducted at the room temperature
it did not show any trace of material absorbing at
284 mp even after 24 hours.
The reaction was repeated at room temperature
, . : rU t • < v- ■ '
using 580 mg. of the mixture of the diols. The product
was sampled every hour and used for ultraviolet
. . I : ■; , '1 i 5 ' '11 1
spectrophotometry and thin-layer chromatography!;
the optical density at 242.5 mp was measured and the
amount of total product formed calculated. The
results are given in the form of a graph which shows
that about 60% of the starting material was converted
into the product cholest-4-en-3-one-7a -ol within the
first hour of the reaction. That the reaction was
complete after 8 hours was shown by TLC and ultra¬
violet spectrophotometry determinations. The product
did not show any trace of material absorbing at 284 rap
even after 24 hours.
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The compound, cholest-4-en-3-one-7a-ol, has been
found to be unstable on alumina (Danielsson, 1961a),
the 7-hydroxyl being in the less preferred axial (a)
configuration undergoes dehydration to cholest-4, 6-
diene-3-one. But when deactivated alumina was used
for its chromatography, dehydration did not occur and
the product was isolated pure.
The experimental procedures for this oxidation and
the purification of the product are outlined later.
Selective Reduction of the 4, 5-Double Bond in
Choiest-4- en- 3 -one* 7a -ol
A selective reduction of the 4, 5-double bonds of
6en.
steroids to a 5{3-hydrohy4 and thus compounds of the
coprostane series, can be brought about by
hydrogenation at a low temperature (Grasshof, 1934;
Nickon and Bagli, 1961). These findings were applied
to cholest-4-en-3-one-7a -ol and the compound was
hydrogenated at >27*. The reaction was studied by
-98-
foilowing it every hour by the usual methods of TJLC
and spectrophotometry. Five hours' hydrogenation
was found to be sufficient to reduce the double bond
without affecting the keto group at position 3 (Fig. 21 and
By this method coprostan-3-one~7a-ol was obtained in
good yield.
Reduction of the Coprostan-3-one-7a-ol
The reduction of 3-ketones of the coprostane series
is known to give the 3o -isomer as the major product,
when the reaction is conducted in a neutral medium
(Ruzicka et al. 1934; Barton et al. 1949).
Coprostan-3-one-7a-ol was reduced with lithium
aluminium hydride or sodium borohydride to give
coproetan-3a, ?a-diol. The same product can also be
obtained if cholest-4-en-3-one-7a-ol is hydrogenated
at room temperature in a neutral medium.
The hydrogenation at room temperature is not
selective and also affects the 3-ketone. In view of the
fact that the reduction of the 3-ketone of the coprostane
series predominantly gives the 3a-isomer it is not
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surprising that in both cases the product was
predominantly the 3a-isomer (shown by TLC). The
3p-isomer can easily be removed by crystallization of
the product or by treatment with digitonin. That the
product is coprostan-3a, 7a~diol has been shown by
comparison with an authentic sample prepared by a
Kolbe's synthesis as described by Bergstrom and
| Krabisch (1957).
The advantages of this route for the synthesis of
coprostan-3a. 7a -diol and analogues of this substance
are J the overall yields are good while the starting
material, cholesterol, is inexpensive. The chemical
synthesis proceeds through the same intermediates as
proposed for biological degradations. The method can
be applied to a large number of A5-steroids having
hydroxyl groups elsewhere in the molecule and so a





The compound was obtained by Oppenauer
oxidation of cholesterol according to Nickon and Bagli
(1961).
Cholesterol (75 g.) and 450 g, of p-benzoquinone,
freshly crystallized from petroleum ether (100-120)
in 4. 375 litres of pure dry toluene (previously
purified with concentrated HjSO^, washed, dried over
CaClg and redistilled over sodium) was heated to reflux
temperature and 100 g. of powdered aluminium iso-
propoxide was added in small portions with sufficient
time to allow the vigorous reaction to subside. The
mixture was refluxed for 2 hours and then diluted very
cautiously with 2. 5 litres of hot water and steam-
distilled for 5 hours. All the toluene distilled over in
about 4 hours. The reaction mixture was brought to
0* and acidified with IN-HjSO*. Constant stirring
during the addition of the acid gave a fine slurry of
the reaction mixture which was left at 3*C overnight
-101-
and then filtered under suction. The solid and the
filtrate were extracted with ether separately. The
ether extracts were pooled together( washed with IN-
H35SO4 and then with water, bicarbonate, and again with
water. Evaporation of the dried ether extracts gave a
dark brown residue which was thoroughly dried under
vacuum and dissolved in dry benzene and chromatographed
on 750 g. of 'activated* alumina (p. 43). Elutions
with benzene, 10% ether in benzene and then 20% ether
in benzene, took off all the cholest-4, 6-diene-3-one
leaving a brown residue on the column. The different
eluates were shown by thin-layer chromatography
(benzene:petroleum ether:ethyl acetate, 40:20:5) to
have only one spot (Rp O S'S? Evaporation of the
combined eluates gave a pale yellow residue which on
crystallization from methanol gave colourless needles
(35 g.).
rn. p. = 81. 5* C C and H (C27H42°)
Amax. = 284 mp Found C = 84,70% Theory
c*84 = 29,000 H = 11. 28%
MB s +36
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Study of the Reaction Rate of the Epoxidation Reaction
i) At room temperature (18*C)
Choiest-4, 6-diene-3-one (0.100 g.) was dissolved
in 5 ml. of ether solution of monoperphthalic acid
containing 0.155 g. of the acid, and 1.5 ml. of
chloroform was added and the mixture left at room
temperature. A sample was taken out every 4 hours
and two spots put on a fluorescent thin-layer plate and
the chromatogram developed in benzene:petroleum ether
1 ; / ' • • •' - « '• .> ' v - ' ' ' ' ' ' ; • : '
O
(60r80):ethyl acetate (40:20:5) solvent system. The
chromatogram was viewed under a u.v. lamp and the
-' • ■ ■ • • "
two dark spots corresponding to cholest-4, 6-diene-3-one
and cholest-4-en-5-one-6a , 7a-epoxide were eluted
separately (ether alcohol) and the optical densities
measured at 284 mp and 241 mp respectively. The
other half was sprayed with phosphomolybdic acid (PMA)
in ethanol solution (1%) to find if there were any other
products formed.
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The results obtained are plotted in the form of a
graph (Fig. 18) which shows that within 5 hours the
amount of the epoxide formed is about as much as the
amount of unchanged cholest-4, b-diene-3-one. The
reaction then slows down and reaches an equilibrium in
70 hours.
At the end of 100 hours, the reaction mixture was
filtered through 'neutral' alumina (10 g.) and eluted
with another 50 ml. of chloroform. The eluates were
evaporated and the residue (0.072 g.) was dissolved in
petroleum ether (60-80) and chromatographed on
'deactivated' alumina (3% water in neutral alumina).
The column was washed with petroleum ether and then
10% benzene in petroleum ether. Elution with 20% and
25% benzene in petroleum ether gave the starting diene-
one. Thirty percent of benzene in petroleum ether
started eluting the epoxide also. Continued elution with
30% benzene in petroleum ether and then benzene gave
the epoxide; these eluates were evaporated and the
residue crystallized from methanol to give fine
colourless needles (0.031 g.).
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The reaction was repeated with the same amount of
... •
; . • • " . " ' - ; ; i • ; '• • . ' • - 1 ' 1 ' ; • , ; 1 ' v ' ' ; '
the starting material and followed in the same way and
worked up as usual. The results are summarized in
! Fig. 18. j
iii) At 37*
The results obtained by performing the reaction at
37* are summarized in Fig. 18.
Cholest—4-en-3-one-6a , 7a -epoxide
Choiest-4, 6-diene-3-one (5, 2 g,) was dissolved in
80 ml. of ether solution of monoperphthalic acid
(containing 8 g. of the acid) and 25 ml. of chloroform
added and the mixture left at 37*. The reaction was
stopped after 25 hours and worked up as described.
m. p. * 136*
X max. =
*214 s 15» 600
- 1 05-
The residue (3. 66 g.) was chromatographed on
'deactivated' alumina (25 g.) (3% water in neutral
alumina) and the unchanged starting material eluted with
20% and then 25% benzene in petroleum ether. The
epoxide was eluted with 30% benzene in petroleum ether.
Evaporation of these eluates and crystallization of the
residue from methanol gave colourless needles (1.76 g,),
m,p, = 136° C and H (^27H42Qz)
<*41 = *5» 600 Theory C = 81.4% Found C = 8jj. 3%
[a] {J = "57* H= 10.45% H=lJ.04%
1R ( V ) = See Appendix Fig. 6
-106-
REDUCTION OF CHOLEST-4-EN-3-ONE-6a , 7a-EPOXIDE
i) With Potassium Borohydride at -5*
Cholest-4-en-3-one-*?a, 7a-epoxide (100 mg.) was
dissolved in methanol (10 ml,) and cooled to -5* and
added to a cooled suspension o£ potassium borohydride
(100 mg,) in methanol (5 ml.). The reaction mixture
was kept stirred and was tested by fluorescent TEC
after every 10 minutes; the samples showed two spots,
one u,v. absorbing corresponding to the starting
material and the other non-u. v. absorbing which gave a
brownish colour with phosphotungstic acid. After 4
hours, analysis on a thin-layer chromatogram showed a
very slight trace of some more polar material
presumably the diol. The reaction was stopped after
5 hours; the excess of the reagent was decomposed
with water and the product extracted with ether.
Evaporation of the residue and crystallization from
methanol gave 58 mg. of cholest-4-en-3a-ol-6a , 7a-
epoxide shown as pure by TL.C and other methods.
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^■27^44Qz requires C = 81.0%
H = 11.0%
m.p. = 108* Found C = 81.65%
H = 11. 15%
IR ( V ) - See Appendix Fig. 7
This compound (15 mg.) when oxidized with
manganese dioxide (150 mg.) in chloroform (5 ml.)
for 4| hours gave the starting epoxide shown by mixed
melting point, ultraviolet and infrared spectroscopy and
co-chromatography on TLC.
The compound (cholest-4-en-3a-ol -6a, 7a-epoxide)
when reduced with lithium aluminium hydride gave a
compound identical with cholest-4-en-3a, 7a-diol.
ii) Reduction with Lithium Aluminium Hydride
(Mixture of cholest-4-en-3a, 7a-diol and cholest-4-en-
3p. 7a -diol)
Cholest-4-en-3-one-6a , 7a-epoxide (630 mg.) in
7 ml. of tetrahydrofuran (freshly distilled over sodium)
-108-
was added slowly to a suspension of lithium aluminium
hydride (1.0 g.) in tetrahydrofuran (3 ml.) and then
refluxed for 30 minutes. After cooling, the excess
....
reagent was decomposed with ether-ethyl acetate and
the whole poured into a saturated solution of
Roehelle salt and extracted with ether. The ether
solution was dried over sodium sulphate and evaporated
to dryness giving 590 mg. of a residue containing
cholest-4-en-3a, 7a-diol and cholest-4-en-3j2, 7a -diol.
The two isomers were not resolved at this stage and
s
were used for the next preparation as such.
,
Thin-layer chromatography (benzene:ethyl acetate:
acetone, 100:50:30) showed two spots corresponding
to the 3p, 7a -diol and the 3a, 7a -diol. Infrared
spectrum showed large hydroxyl peaks and no carbonyl.
That the reduction was complete was also shown by
■
the absence of ultraviolet absorbing material at 241 mp. .






The mixture of the diols cholest-4-en-3a , 7a -diol
and cholest-4-en-3{3, 7a-diol (580 mg.) was dissolved
in chloroform (80 ml.) and manganese dioxide (5 g.)
added. The mixture was shaken for 12 hours at room
temperature, and 1 ml. aliquots were taken out every
2 hours and used for ultraviolet spectrophotometry
determinations and thin-layer chromatography. After
12 hours the product was filtered and washed with hot
chloroform, the filtrate evaporated and the residue
dried thoroughly by suction. The dry residue (550 mg.)
was dissolved in 90% benzene in petroleum ether and
chromatographed on 'deactivated' alumina (40 g.) (10 ml.
water per 100 g. of neutral alumina). The column was
washed with benzene and cholest-4-en-3-one-7a-ol,
eluted with 2% ether in benzene and then 5% ether in
benzene. The combined eluates were evaporated to
dryness in vacuo and crystallized from ethyl acetate
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Further elution with 10% ether in benzene and then
ether, eluted the unchanged 'diol mixture*. These
eluates were pooled and added to the previous test
aliquots and evaporated under vacuum. The dried
residue was reoxidized with MnC>2 in CHClj. This time
the mixture was le£t shaking for 24 hours. It did not
show any absorption peak at 284 mp and the same work¬
up procedure as before gave another 37 mg. of
cholest-4-en-3-one-7o -ol.
Coprostan-3-one-7a -ol
By selective hydrogenation of cholest-4-en-3-one-7a-ol.
i) Study of the Rate of Reaction
Cholest-4-en-3-one-7o-ol (15 mg.) was dissolved




Found C = 80.92% Theory
H = 11.2%
[a} ^ = +67
IR ( V ) * See Append
C = 80,95%
H * 11. 1%
ix Fig. 9
SYNTHESIS OF COPROSTAN—3-ONE—7«—OL.
1-5 a HYDROGENATION OF CHOLEST—4—EN—3—ONE—7«—Ot(iyc IN ETHER AT-27°C)
Figure 21
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added and the mixture cooled to -27* and hydrogenated
at this temperature. Fixed amounts of the reaction
mixture were taken out every hour and a known amount
of it was evaporated and dissolved in ethanol and the
optical density at 242. 5 my. measured. The other
portion of the sample was used for TLC. After 1 hour
^ 5 mg. of the starting material had disappeared and
the TLC showed two spots, one u.v. absorbing
corresponding to the starting a, (3-unsaturated ketone
and the other non-u. v. absorbing corresponding to the
saturated compound coprostan-3-one-7o -ol. Such tests
every hour showed that the reaction was complete in 5
hours, TLC showed traces of some more polar
material also. The results are shown in Fig. 21 and 22.
The product was filtered and the filtrate evaporated and
the residue used for preliminary chromatography of the
product from the more polar compounds.
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The above hydrogenation experiment was repeated
with 50 mg. of the cholest-4-en-3-one-7a-ol and 8 mg.
samples were taken out and the reaction was stopped
after 5 hours and the product worked up as above.
The residue,was chromatographed on neutral alumina
(20 g.). Elution with benzene and then 5% ether in
benzene eluted some less polar material. Coprostan-
3-one-7o-ol was eluted with 20% and then 30% ether in
benzene. These eluates were pooled together and
evaporated and the residue crystallized from ethanol
(38 mg.).
m, p. = 121"C
A
+16 czth46°z requires C = 80. 67%
H = 11.44%
IR ( ) = See Appendix Found
Fig. 10
C = 80. 84%
H = 11.37%
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Coprostan- 3a -7a -diol
*) By reduction of coprostan-3-one-7a-ol with
lithium aluminium hydride.
Coprostan-3-one-7a -ol (12 mg.) was dissolved in
1 ml. of tetrahydrofuran and added to lithium aluminium
hydride (20 mg.) and reftuxed for 15 minutes. The
product was worked up as described in the procedure
for the reduction of epoxide and crystallized from
ethyl-acetate.
**) By direct hydrogenation of cholest-4-en-3-one-
7a -ol at room temperature.
Cholest-4-en-3-one-7a-ol (60 mg.) was dissolved
'
in 5 ml. of dry ether and 8 mg. 10% palladium-on-
charcoal added and hydrogenated at room temperature
for 6 hours. The catalyst was filtered off, washed
with warm ether, and the filtrate and washings were
evaporated to dryness. Thin-layer chromatography
showed one main and three other trace spots but there
was no starting material left.
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Chromatography on 12.5 g. of 'deactivated'
alumina (6% water added to neutral alumina) and
elutions with 3% ether in benzene and then 5% ether in
benzene gave one spot on thin-layer chromatography.
The eluates were evaporated to dryness and the
residue crystallized from ethyl-acetate. Recrystalliz-
ation from acetone-alcohol gave 30 mg. of colourless
crystals.
iii) From cholest-4-en-3-one-7a-ol or cholest-4-
eE/»3-one-6a, 7a-epoxide through a saturated intermediate.
Cholest-4-en-3-one-7a-ol or the epoxide (15 mg.)
was dissolved in dry ether (4 ml.) and 10% palladium-
on-charcoal (4 mg.) added and hydrogenated at -27*.
After 4 hours the cooling bath was removed and the
product hydrogenated at room temperature for another
4 hours. The catalyst was filtered off and washed with
warm ether. The ether solution was evaporated and
dried which gave a colourless solid residue.
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In all the three methods described above the
colourless solid residue obtained after the evaporation
of the eluates melted at 188-192*» but when it was
crystallized from methanol or acetone alcohol the
melting point was 78.79* (cf. Bergstrom and Krabisch,
1957). Recrystallizations with ethyl acetate did not
change the melting point (78-79*) of this material.
m.p. a 78-79* Mixed m.. p. = 7g - 7q°
fa) » +14
IR ( y ) » See Appendix Fig. 11
Choiest-4- en-3a, 7a -diol
Reduction of choleBt-4»en-3-one-6a, 7a-epoxide
Cholest-4-en-3-one-6a, 7a-epoxide (100 mg.) was
reduced with lithium aluminium hydride in tetrahydro-
furan as described previously. The crude mixture of
diols (predominantly 3a-isomer - shown by TLC) was
dissolved in alcohol and treated with digitonin (45%
alcoholic solution). The supernatant was extracted with
ether. The dried solution of ether was evaporated and
the residue crystallized from methanol which gave
-116-
colourless crystals (65 mg.).
m. p. = 98* C CzTHUtQt requires C = 80.5 3%
H * 11.44%
[a.]-}) a +97 found C = 79.65%
IR (y ) = See Appendix H » 11.51%
Fig. 8
Tritium Labelled Cholest-4-en-3-one-7a-ol
Fifty milligrammes of the compound were randomly
labelled with tritium by leaving the compound in contact
with tritium for two weeks (Wilzbach method). The
labile tritium was removed as usual (p. 55) and the
product run on a fluorescent thin-layer chromatogram
(benzene:ethyl acetate. 2:1). The chromatogram
showed one u.v. absorbing spot. It was cut into ten
parts and each was eluted separately and counted. The
counting showed three radioactive peaks, one
corresponding to cholest-4-en-3-one-7a-ol, the other
less polar and the third more polar than this compound.













Several crystallizations with methanol did not
improve the quality of the product. The crystalline
product was dissolved in 35% ether in petroleum ether
(60*80) and chromatographed on 20 g. silicic acid
(washed with ether and then methanol and dried at 100*
for 24 hours). The column was washed with 35%
and then 40% ether in petroleum ether which eluted some
less polar material; the cholest-4-en-3-one-7a-ol
was eluted (shown by TJLC and counting) with 42% and
43% ether in petroleum ether. These cuts were
evaporated and the residue crystallized from ethyl
acetate to give 12 mg. of the labelled compound,(Fig. 23)»
m. p. = 183* Specific activity = 7. 8 x 10* c. p.m./mg.
Another sample of the compound (30 mg. ) was
labelled in the same way but giving it only 72 hours'
exposure. The product was worked up as usual. It
'
showed very little amounts of some less polar and some
more polar material. Chromatography as above gave
the pure labelled cholest-4-en-3-one-7a -ol in better
yields (18 mg.).
m.p. = 183* Specific activity = 500, 000 c.p.m./mg.
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Summary
Thin-layer chromatography has been used for the
study of a number of steroid reactions;
Coprostan-3a, 7a-diol has been synthesized by a
six-stage synthesis from cholesterol. The synthesis
proceeds through compounds which have been proposed
as intermediates in the biosynthesis of this compound
from cholesterol; cholest-4-en-3-one-7a-ol and
coprostan-3-one-7a-ol have been synthesized from
,, 11. i •
cholesterol as intermediates in the above synthesis.
The synthesis of two new compounds, cholest-4-
en-3a -ol-6a, 7a -epoxide and cholest-4-en-3a, 7a -diol,
has been described.
A method of selective reduction of steroid-3-ketones
is described. The method of selective reduction of a
double bond at reduced temperatures has been applied
to cholest-4-en-3-one-7a-ol to synthesize coprostan-
3-one-7a-olt
Choiest-4-en-3-one-7a-ol has been labelled with
tritium and purified.
SECTION V
STUDIES ON POSSIBLE INTERMEDIATES




It has been discussed (p . 20) that in the
degradation of cholesterol to bile acids the cleavage of
the cholesterol side-chain possibly proceeds through
hydroxylated intermediates; 26-, 25-, and 24-hydroxy-
cholesterols are possible intermediates. In this work
these hydroxylated derivatives have been synthesized by
different methods.
Cholest-5-en-3j3-26-diol has been prepared from
kryptogenin by the method of Scheer et al. (1956).
These authors noticed that a Clemmensen reduction of
the plant sterol kryptogenin, cholest-5-en-3p-26-diol-
16, 22-dione, did not reduce the 16-carbonyl as
effectively as it reduced the 22-carbonyl and the
reaction product was a mixture of cholest-5-en-3|5-
26-diol and cholest-5-en-3p-26-diol-l6-one. They also
reported that if the sterol was subjected to a Huang-
Minion reduction (Huang-Minion, 1946, 1949) they got a
resinous product which could not be crystallized.
-120-
Xn this work these two observations have been
confirmed. When kryptogenin was reduced by a Huang-
Minion method the product was a gum which on TLC
showed three spots and could not be purified because of
its resinous nature. The Ciemmensen reduction of
the sterol gave a solid colourless precipitate, also
giving three or four spots on TLC.
The Ciemmensen reduction of kryptogenin was
followed every 20 minutes by TLC; a sample was taken
out and half of it was poured into cold water and the
other half put on to a thin-layer chromatogram. The
product, from the first half, was extracted with ether
and a spot of this also put on TLC. The developed
chromatograms were identical in both cases. The
reaction was stopped after 2 hours since the chromato¬
gram showed traces of some new products at this
stage. Several methods were used for the isolation of
the product of this reduction. The product was either
acetylated and the isolation of cholest-5-en-3p-26-diol
diacetate effected by chromatography of the diacetates,
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or it v/as subjected to a Huang-Minion reduction to
remove the 16-carbonyl of the unchanged cholest-5-en-
3p-26-diol-l6-one, or it was reduced with borohydride
and chromatog raphed.
In the chromatography of the acetylated mixture
(cholest-5-en-3p-26-diol-diacetate and 3p-26-diacetoxy-
cholest-5-en-l6-one) on alumina it was noticed that the
primary alcoholic acetate at C24 readily underwent a
hydrolysis to give a free hydroxy! in that position
(shown by infrared spectrum and the chromatographic
behaviour of the product). The acetate group at C5 also
formed a free hydroxyl but not as readily as the one at
Cjti (cf. Johnsand Jerina, 1963), These products were
not isolated pure,
3j3-26-Diacetoxy-cholest-5-en- 16-one was obtained
as a by-product from the chromatography of the
diacetates. Some of this product was hydrolysed to get
the free keto-diol, cholest-5-en-3p-26-diol-16-one.
-122-
In the Clemmensen reduction of kryptogenin in
addition to the cholest-5-en-3|3-26-diol and the cholest-
5-en-3p*26-diol-l6*one, another product (compound X)
was obtained which could not be identified. Its
chromatographic behaviour suggests that it has only one
hydroxyl and no other polar substituents; infrared
'
spectrum shows .ahydroxyl peak and no carbonyl
absorption (Appendix Fig. 16); the compound has a
sharp melting point and runs as a single spot on TLC.
Cholest-5-en-3p-26-diol was labelled with tritium
by the Wilzbach method (Wilzbach, 1957). Longer
exposures with tritium led to several artifacts (shown
by TLC and scintillation counting) and the compound
could not be purified either by crystallization or by
chromatography. The product was then acetylated and
the pure tritium4abelled cholest-5-en-3(3-26-diol-
-123-
diacetate isolated by chromatography on 'neutral'
alumina (see Fig. 26 and 27). For the
labelling of another batch of cholest-5-en-3p-26-diol,
the compound was given a shorter exposure (72 hour)
with tritium which did not produce as many artifacts and
the compound could then be purified by crystallization
only.
For the synthesis of cholest-5-en»3p-25-diol
a known method (Ryer, Gebert and Murrill, 1950;
Dauben and Bradlow, 1950) was used. 25-Keto-nor-
cholest-5-en-3£-acetate obtained from Steraloids Inc.,
New York (for the synthesis of this compound see
Ruzicka and Fischer, 1937) was treated with methyl-
magnesium iodide to get the product which was purified
by chromatography on alumina.
Cholest-5-en-3p-24-diol has been prepared by a
sequence of reactions according to Riegel and Kaye
(1944). For the synthesis of this compound 3f--hydroxy-
chol-5-enic acid was prepared from hyodeoxycholic acid
(Bharucha et al. 1956). For the preparation of the acyl
-124-
chioride of 3f3-hydroxy-chol-5-enic acid some workers
(Kuwada and Yago, 1937; Cortese and Bauman, 1935)
have used thionyl chloride but oxalyl chloride was
found to be superior.
Since the acyl chloride is very unstable because of
the easily ionizable chlorine atom, the purity of the
compound could not be checked by the usual methods,
viz. TLC, infrared absorption spectrum, optical
rotation, etc. The estimation of the chloride was
found to give a satisfactory criteria of the purity of the
compound. The acyl chloride 3p-hydroxy-chol-5-enyl-
chloride was treated with a Grignard reagent prepared
from 2-bromopropane, magnesium and cadmium
bromide in ether, and the resulting 3j3-acetoxy-cholest-
5-en-24-one hydrolysed to get the free hydroxy-ketone
or was reduced with a metal hydride reagent to give the
diol which was purified by chromatography^^
Cholest-5-en-3jS-24-diol was also prepared by the
ozonolysis of fucosterol. Fucosterol is a 5, 6-
unsaturated Q? plant sterol having a =CH. CHS group
-125-
attached at Ca4. The rest of the molecule is like
cholesterol. This sterol has been found in all species
of the brown marine algae and can be extracted easily
*rom ^ucus Veaiculosus. Since the molecule is like
cholesterol and it has a =CH. CH3 group attached at Cjw,
it will be expected to give 24-ketocholesterol on ozonolysis.
Fucosteryl acetate was ozonized by a slow stream of
the gas at room temperature (Hey, Honeyman and Peal,
1950). The hydrolysed product was found to be
identical with cholest-5-en-3p-ol«24-one prepared by
the previous method. Reduction of this hydroxy ketone
with lithium aluminium hydride gave the dioL (Fig. 28).
As pointed out in the introduction, the 3a, 7a, 12a »
trihydroxy coprostanic compounds having oxygen
functions at Cg* have been shown to convert into cholic
acid less efficiently than the corresponding compounds
without an oxygen function at C24 (p. 27). Such
studies with 3a, 7a -dihydroxy-24-oxo compounds have
not been undertaken because no such compounds have
yet been synthesized.
COPROSTAN — 3oc.7oc-OIOL— 24-ONE
Figure 24
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; Cole and Julian (1945) and Shimizu, Noda and
Yamasaki (1958) evolved a method of preparing steroids
with a keto group in the side-chain. Applying this
method, coprostan-3a, 7a -diol-24-one has been
synthesized by a series of reactionsC^i^ Zh)
3a, 7a-Dihydroxy-cholanic acid (chenodeoxycholic
acid) was prepared from cholic acid by a selective
hydrolysis of 3a, 7a, 12a-triacetoxy-cholanic acid at Cji
and the subsequent oxidation at this position (Cut) and
then removal of the 12-carbonyl by a Huang-Minion
reduction (Hoffman, 196ij Fieser and
1950). The pure chenodeoxycholic acid was acetylated
to get the 3a, 7a-diacetoxy-cholanic acid which gave
3c., 7n -diacetoxy-cholanyl chloride by treatment with
oxalyl chloride. This acyl chloride gave a correct
value for the chloride and that was taken as a criteria
of its purity. 3a, 7a-Diacetoxy-coprostan-24-one was
obtained by a Grignard reaction with 3a, 7a -diacetoxy-
cholanyl chloride and 2-bromopropane. The reaction
product was hydrolysed and 3a, 7a -dihydroxy-coprostan-
24-one isolated pure. Several solvents were tried
to crystallize this product but it gave a gum which
did not crystallize. The
-127-
solvent was then evaporated and the product dissolved in
ether and evaporated. This treatment when repeated
three times gave a dry solid residue which was crushed
to a powder. It gives a single spot on TLC in two
different solvent systems. Its infrared absorption
spectrum shows a hydroxyl and a side-chain ketone
(Appendix Fig. 3 2).
It will be of considerable interest to test this
compound and the corresponding 3, 24-diol, coprostan-
3. 24-diol, on a bile fistula animal and see if it is
converted into chenodeoxycholic acid (cf. p. 37),
Shimizu et al. 1959).
-128-
Methods of Synthesis
Cholest-5-en-3ft, 26-diol-l6, 22-dione (kryptogenin)
The kryptogenin obtained from Steraloids inc.,
U.S.A., was found to contain several other products
when tested on thin-layer chromatography. Infrared
spectrum and melting point (159*C; lit. 181*) were
also unsatisfactory.
The crude material was leached several times with
cold ether and the solid crystallized from ethyl
acetate. Two crystallizations removed some
impurities but the crystals still showed traces of less
polar material (TLC - solvent system, benzene:ethyl
acetateracetone, 10:5:5). The crystals were
dissolved in 10% methanol in chloroform and
chromatographed on 'active' alumina, Elution with
20% methanol in chloroform eluted the less polar
material and eluates from 50% methanol in chloroform
and then 100% methanol gave kryptogenin.
Crystallization from ethyl acetate afforded colourless
-129-
needles.
m. p. = 183* C & H Theory Found
(C27H40O4)
C = 75-3% C = 75-1%
H = 9.7% H = 9.6%
III { V ) Impure sample = See Appendix Fig. 13
Purified samples See Appendix Fig. 14
A further crop of pure material was obtained when
the ether extracts and the mother liquors from different
crystallizations were pooled together, evaporated and
chromatographed.
A 20 g. batch of kryptogenin obtained from Lights
(L, Light and Co., Ltd., England) was found to be of a
better quality but showed traces of two less polar
products which were removed by two crystallizations
with ethyl acetate and the crystalline product gave a
single spot on TLC.
m. p. = 183*
Gholest-5-en-3p, 26-diol (26-hydroxycholesterol)
Clemmensen Reduction of Kryptogenin
Zinc amalgam (40 g.) (prepared by shaking for






















































! chloride in 100 ml. of water and 3 ml. of concentrated
H&) was taken in a 500 ml. R. B. flask fitted with a
condenser. Kryptogenin (1.5 g.) was dissolved in
150 ml. of 95% ethanol and added to the flask and the
mixture heated to reflux; 60 ml. of concentrated HC1
were added in small portions over a period of 2 hours
... : .;,■■■■ . , , ■■■■'
and the mixture kept refluxing for another 30 minutes.
The reaction mixture was sampled out every 20 minutes
and run on TL*C (benzene:ethyl acetate. 2:1). The
starting material disappeared during the first 20
minutes and the product showed two main spots, one
corresponding to the cholest-5-en-3£, 26-diol and the
other slightly more polar presumably cholest-5-en-3(3, -
26-diol-l6-one. In the subsequent TLG this latter
compound seemed to decrease while 26-hydroxycholesterol
was increasing. The chromatograms also showed a
spot (Rp 0. 78) less polar than 26-hydroxycholesterol.
After 2 hours the chromatograms showed two more
polar spots and the reaction was stopped at this stage^Fug Z5)
the reaction mixture was allowed to cool and was then
poured into cold water and the product extracted with
ether, evaporated and dried.
TL.C of the dried product showed two main spots and
one small less polar one and two trace spots of more
polar material. Two crystallizations from ethyl
acetate removed the small spots and the crystals
(0.82 g.) showed only two spots corresponding to the
diol and the keto-diol. Further crystallization did not
separate the two compounds. The 26-hydroxycholesterol
was isolated from the mixture by chromatography of
the diacetates.
Compound 'X'
The supernatant from the above ethyl acetate
crystallization was evaporated to dryness and re-
crystallized from ethyl acetate which gave a product
'X' running as a single spot on TJLC (Rp = 0.78;
benzene:ethyl acetate, 2:1). The chromatographic
-132-
behaviour suggests one nuclear hydroxyl group; it gives
a single spot on TLC in two different solvent systems and
'
has a sharp melting point. The infrared spectrum shows
a hydroxyl peak but no carbonyl.
m. p. =116* C & H Theory Found
I v
C = ? C = 78-56^





Isolation of Choiest-5-en- 3ft, 26-diol
The isolation of the cholest-5-en-3(3, 26-diol from
the Clernmensen reduction product was effected by
different methods.
i) By chromatography of the diacetates
Acetylation of the mixture
The crystalline product (mixture of cholest-5-en-
3(3, 26-diol and cholest-5-en-3(3, 26-diol-16-one) obtained
above was refluxed with acetic anhydride for 1 hour,
allowed to cool and then poured slowly into crushed ice




The solid residue obtained above (0.75 g.) was
dissolved in benzene and chrornatographed on 'neutral*
alumina (30 g.). Elution with 0.5% ethyl acetate in
benzene gave a product which gave one spot on TLC
(benzene:petroleum ether:ethyl acetate, 40:60:5).
These eluates were pooled together, evaporated and
crystallized from methanol which gave cholest-5-en-
3fi, 26-diol-diacetate as shining needles (0. 355 g.).
m.p. =119* C&H (C31H50O4)
talis = +11 Theory C = 76.6%
D
IR(V ) = See Appendix H = 10.37%
Fig. 17
Found C « 76.64%
H » 10.53%
Cholest-5-en-3ft, 26-diol (26-hydroxycholesterol)
The above diacetate (200 mg.) was hydrolysed by
refluxing with 30 ml. 5% methanolic KOH for 1 hour.
The product was extracted with ether, washed, dried,
evaporated and crystallized from ethyl acetate to give
-134-
the free compound, cholest-5-en-3£, 26-diol (0.165 g.).
m. p. = 178* C&H (C27H46_Q2)
fa]g = -30 Theory C = 80.6%
IR (V ) = See Appendix H = 11.4%
Fig. 18
Found C = 80.5%
H = 11.3%
, . i , ; ■ . ,
p .
3p, 26-Diacetoxy-cholest-5- en-16-one
Continued elution of the above column (chromato¬
graphy of the diacetates) with 5 % ethyl acetate in
benzene gave a product which gave one spot on TL>C
(benzene:petroleum etherrethyl acetate, 40:60:5). The
!
■
eluates were evaporated and crystallized from methanol
to give shining needles of 3p, 26-diacetoxy-cholest-5-
en-16-one (0. 22 g*).
m. p. =
w g =
IR (\) ) =
H = 10.6%
116* C&H (C31H4805)
-118 Theory C = 77.8%
See Appendix H = 10.5%
Fig. 19
Found C « 77.6%
-135-
Cholest-5-en-3p, 26-diol-l6-one
The compound (35 mg.) was obtained by the
hydrolysis of the above diacetate (50 mg.).
m. p. * 171*
[a]g « -155
Further elution of the above column (chromato¬
graphy of diacetates) with 10% and then 25% ethyl
acetate in benzene eluted a product which gave two spots
on TLC (benzene;ethyl acetate, 2:1). The mobility of
these compounds suggests that the less polar one
(Rjp 0.8) has one hydroxyl group and the more polar one
(Rjp 0.58) has a ketone in addition. The infrared
spectrum of this product shows a hydroxyl as well as a
ketone absorption (see Appendix Fig. 20).
These two products seem to have formed by the hydrolysis
of the primary alcoholic acetate group at Cu (cf. Johns
and Jerina, 1963). The two products were not
separated for any further investigation. Forty percent
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and 50% ethyl acetate eluted two more polar products
which behaved like cholest- 5 - en- 3p, 26-diol and
cholest-5-en-3|3, 26-diol-16-one. The infrared
spectrum shows a carbonyl and a hydroxyl absorption.
These compounds seem to have been formed by the
complete hydrolysis of the diacetates on the alumina
column (cf. Johnsand Jerina, 1963).
All these eluates (10% to 50% ethyl acetate in
benzene) were pooled together and hydrolysed with KOH.
The product of hydrolysis showed two spots on TLC
(benzene:ethyl acetate:acetone, 10:5:3) corresponding
to cholest-5-en-3p, 26-diol and cholest-5-en-3£, 26-diol-
16-one (0.090 g.). This shows that the two less polar
products obtained above (eluates from 10% and 25%
ethyl acetate in benzene) were, indeed, products of
partial hydrolysis of the diacetates.
ii) By Huang-Minion reduction
Kryptogenin (1. 8 g.) was reduced first by a
Clemmensen method. The mixture of cholest-5-en-
3(3, 26-diol and l6-keto-cholest-5-en-3p, 26-diol
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obtained by this Clemmensen reduction of kryptogenin
was mixed with the same mixture obtained from the
chromatography of the diacetates (after saponification
of the residue from ethyl acetate and methanol eluates,
p. 13 6, and was subjected to a Huang-Minion
reduction (Huang-Minion, 1949).
The above mixture (0. 75 g,), 15 ml. of triethylene
glycol, 1.5 ml. of hydrazine hydrate and 1.3 g, of KOH
were heated at 150-165* on a sand bath in a flask fitted
with an air condenser. The condenser was removed
after 2 hours and the temperature allowed to rise to
185* and kept there for 1 hour. The reaction mixture
was allowed to cool and then poured into cold 1N-HC1
while stirring. The precipitate was filtered, washed





iii) By reduction with sodium borohydride
The mixture (250 mg.) was dissolved in 10 ml, of
methanol and added to a methanolic solution (10 ml.)
of sodium borohydride (250 mg.) and the solution left
at room temperature for 1 hour. The reagent was
decomposed with water and the product extracted with
ether-methanol. The extracts were dried and
evaporated and the residue chromatographed on alumina
.
(Peter Spence type 'O'). Elution with 5% and then 10%
methanol in ether eluted the ^6-hydroxycholesterol.
These eluates were pooled together, evaporated and
crystallized from ethyl acetate,
m. p. = 178
(a] = -30
That the products obtained by the three methods
described above were identical was shown by mixed
melting point. There was no depression.
'°5%
CHROMATOGRAPHY OF TRITIUM-LABELLED CHOLEST—S-EN-Jj», 26-D1 ACETATE.
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Tritium Labelled Choiest-5-en-3ft, 26-diol
The compound (75 mg.) was left exposed with
tritium for two weeks. The labile tritium was removed
in the usual way. TLC of the product at this stage
showed three radioactive peaks. Chromatography on
alumina or silicic acid and repeated crystallizations did
not improve the quality of the product. The dry product
was treated with acetic anhydride to get the diacetate
which was chromatographed. The product was
dissolved in petroleum ether and adsorbed on neutral
alumina. Increasing amounts of benzene in petroleum
ether eluted one radioactive peak in the eluates from
20% to 30% benzene in petroleum ether. The cholest-
5-en-3{3, 26-diol-diacetate was eluted with benzene and
then 0. 5% ethyl acetate and 2% ethyl acetate in benzene.
Continued elution with increasing amounts of ethyl
acetate in benzene eluted some more polar material.
The results are shown in the form of a graph (Fig. 26
and 27).
TRITIUM LABELLED 26-HYDROXY CHOLESTEROL. TLC./SCINTILLATION COUNTING.
% BENZENE 2
ETHYL ACETATE 1-25





The cuts consisting of the cholest-5~en~3f , 26-diol-
diacetate were pooled together* evaporated and the
residue crystallized from methanol.
The diacetate was hydrolysed with methanolic KOH
to give the free compound (17 mg.).
m. p. = 178*
Specific activity = 8.96 x 10* c.p.m,/mg.
In another run. 30 mg. of the compound were left
in contact with tritium for only 72 hours. The product
in this case showed very little of the artifacts and was
sufficiently radioactive. After removal of the labile
tritium in the usual way the product was crystallized
three times with ethyl acetate and once with methanol
which gave a pure product.
m.p. * 178*
Specific activity = 5. 6 x 104 c. p.m./mg.
-141-
Cholest-5-en-3ff, 25-diol (25-hydroxycholesterol)
The compound was prepared by a Grignard reaction
with methyl magnesium iodide and 25-keto-nor-cholest-
5-en- 3p-ol-acetate. The latter compound was obtained
from Steraloids Inc.» New York (m. p. » 141-144*; for
infrared spectrum see Appendix Fig. 21).
A Grignard reagent was prepared from methyl
iodide and magnesium in ether. Dry magnesium (0. 20 g. ]
was dissolved in 1 ml. (1. 13 g.) of methyl iodide in 10 ml.
of ether. A benzene solution of the steroid (500 mg. in
6 ml. of benzene) was added to the reagent and the mixture
refluxed for 3 hours and then left at room temperature
overnight. Ice water (30 ml.) and 50% acetic acid
(2 ml.) was added and the mixture steam-distilled for
about 30 minutes until no more oil passed over; the
product precipitated out as colourless flakes. The
precipitate was filtered, washed and dried. TLC
(benzene:ethyl acetate, 2:1) at this stage showed traces
-142-
of some less polar material {Rjp = 0. 85; Rp of the
diol = 0.5). The dried precipitate was crystallized
from methanol but the crystals still showed some less
polar material. The dried crystals were dissolved in
75% ether in benzene and chromatographed on Active*
alumina (p. 43). Seventy-five percent ether in benzene
and then ether eluted the less polar material and the
cholest-5- en- , 25-diol was eluted with 5% and then
10% methanol in ether. Crystallization of these eluates
from methanol gave colourless crystals (540 mg.}.
m» p. — 182* C& H (C27H45O2)
Wo - Theory C = 80.5%
IR (V ) s See Appendix
Fig. 22
H = 11.4%
Found C = 80.01%
H = 11.6%
METHYL HYODEOXY CHOL/C ACID.
i#2COOCHj
KAC /HAC.
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Hyodeoxycholic acid (25 g.) was dissolved in
methanol (500 ml.) and concentrated HQ (20 ml.) added
and the mixture refluxed for 3 hours. The product was
allowed to cool and then poured, with constant stirring,
into cold 1N-HC1 containing chipped ice. The
precipitate was allowed to settle overnight, filtered,
thoroughly washed, dried and crystallized from
methanol. It showed one spot on TL.C (benzene:ethyl
acetate:acetone, 10:5:3).




To 25 g. of methyl hyodeoxycholate in 50 ml. of dry
pyridine, 28.8 g. of p-toluene sulphonyl chloride was
added at 0* and then left at room temperature. After
C = 74. 07%




48 hours the excess reagent was decomposed with ice and
the mixture poured into ice cold 1N-HC1. The dried
ether extract was evaporated and the residue
crystallized from ethyl acetate,
m.p. = 162-164*
[a] g = 47
IR ( V ) = See Appendix Fig. 23
3ft-Hydroxy-chol-5-enic Acid
Potassium acetate (7.5 g.) was taken in 3.5 ml. of
water and 40 ml. of dimethyl formamide and 2 ml. of
acetic acid added and the mixture heated at 100-105* for
30 minutes. Methyl hyodeoxycholate ditosylate (5 g.)
was then added and the mixture heated at 100* for another
5 hours. The cooled reaction mixture was poured into
ice cold 1N-HC1 and the precipitate dissolved in ether
and washed. The dried ether extract was evaporated
and the residue crystallized from ethyl acetate and then
acetic acid. The product gave one spot on TL»C (benzene:
ethyl acetate:acetone, 10:5:5).
-145-
m.p. « 228-232* C&H (C24H3803)
IR ( V ) * See Appendix Theory C = 76.9%
Fig. 24
H = 10.1%
Found C = 76.53%
H = 9.98%
3ft-Acetoxy-chol - 5 - enic Acid
3ft-Hydroxy-chol-5-enic acid (5 g.), acetic anhydride
(25 ml.) and pyridine (10 ml.) were shaken and left at
■'/: ; ■ ' -
room temperature overnight. The product was slowly
poured into ice and extracted with ether, the ether
extracts washed, dried and evaporated and the residue
crystallized from methanol having a trace of ether to get
pure compound. The crystalline product runs as a
single spot on TLC (benzene:ethyl acetate, 2:1).
m.p. = 152-153* C&H (C26H40O4)
IR ( V ) = See Appendix Theory C = 75.1%
Fig. 25
H = 9.4%




3p-Acetoxy-chol-5-enic acid (5 g.) was dissolved in
5 ml. oxalyl chloride and left at room temperature for
2 hours. Benzene-ether (1:1) (25 ml.) was then added
and the solvents evaporated at reduced pressure. The
process was repeated three times which gave a residue
of white powdery mass. This was dried under reduced
pressure for about 2 hours. The residue gave a
correct elemental analysis for the halogen and was used
for the next step without further purification.
C26H3T03C1 required Q = 8.3%
Found a = 7.9%.
Choiest-5 - en» 3 (3-ol- 24-one
i) By Grignard reaction of 3p-acetoxy-chol-5~ enyl
chloride with 2-bromopropane.
Magnesium turnings (0.600 g.) were gradually
dissolved in a mixture of ether (25 ml.) and 2-bromo-
•
■
propane (3 ml. = 3.6 g.) by shaking vigorously.
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Anhydrous cadmium bromide (7.5 g.) was then added
slowly while the mixture was kept shaken and cool. To
this Grignard reagent was added a benzene solution (7 ml.)
of 3f3-acetoxy~chol-5-enyl-chloride (1.5 g.). The
mixture was refluxed for 1 hour and then left at room
temperature overnight. Crushed ice and then cold
3N-HC1 was added and the ether-benzene layer separated.
The aqueous layer was extracted with more ether-benzene.
,
The extracts were washed thoroughly with water• dried
■
and evaporated. The residue was crystallized twice
j
i •- •
from ethyl acetate and then with methanol which gave
needle-like crystals of 3£-acetoxy-cholest-5-en~24-one.
m. p. =127' C & H (C29H4603)
IR ( V ) = See Appendix Theory C = 78.7%
Fig. 26
H = 10.4%
Found C = 78. 11%
H = 10.30%
-148-
3f3-Acetoxy-cholest-5-en-24-one (0.48 g.) was
saponified with 5% methanolic KOH and the product
extracted with ether. The ether extract was evaporated
and the residue crystallized from petroleum ether to
give cholest-5-en-3p-ol-24-one as needles.
m. p. = 135*
tog = mi5
IR ( V ) = See Appendix Fig. 27
(ii) By ozonolysis of fucosterol
Fucosterol
Fucosterol obtained from Mr E. Booth of the Arthur
D. Little Research Institute, Musselburgh (see also p. I2
was found to contain several other products when tested
on TLC (benzene:ethyl acetate, 2:1). Besides
fucosterol (Rj, = 0.7) the chromatogram showed several
other components more polar than fucosterol. The
compound (2 g.) was dissolved in 25% ether in benzene
which left some insoluble gum weighing about one gram.
That this gum did not contain any fucosterol was shown by
TLC of a chloroform solution of the gum.
-149-
The above ether-benzene (1:3) solution was
chromatographed on 'active' alumina (p. 43). The
column was washed with 25% and then 30% ether in
benzene. Fucosterol was eluted with 50% and then 60%
ether in benzene (500 ml. each). Seventy percent and
80% ether in benzene eluted some more polar material.
J
The eluates containing only fucosterol were pooled and"
evaporated and the residue crystallized from methanol
| (760 mg.).
m. p. = 121* C & H (C29H480)
IR ( )) ) = See Appendix Theory C = 84. 4%
Fig. 28
H *» 11.6%
Found C = 84.41%
H as 11.7 6%
Fucosteryl Acetate
Fucosterol (500 mg.) was refluxed with acetic
anhydride (5 ml.) for 1 hour. The product was poured
slowly into a chilled beaker; the acetate crystcolU^l.
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The crystals were washed with chilled methanol and
recrystallized from ether-methanol (1:9) which gave
495 mg. of the product as shining needles.
m.p. = 119* C&H (C31H50O2)
IR ( )) ) a See Appendix Theory C » 81.9%
Fig. 29
H = H.01%
Found C a 82. 06%
H a 10.95%
Cholest»5-»en-3p*ol»24»one acetate
Fucosteryl acetate (250 mg.) was taken in 10 ml.
of glacial acetic acid and ozone (about 1%) passed
through the suspension for 4 hours. A sample of the
reaction mixture was analysed by TLC every half an
hour. After the first 30 minutes the product showed a
more polar spot in addition to the starting material.
This spot correspondingly increased and after 4 hours
there was no trace of the starting material left. The
ozonization was then stopped and 10 ml. of water added
and the reaction mixture boiled until free from
acetaldehyde. The product was extracted with chloro-
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form, washed and dried. Evaporation of the extracts
and crystallization of the residue from methanol gave
3p-acetoxy-cholest-5-en-24-one as needles (180 mg.).
m.p. = 127-128* C&H (C29H4603)
[a]p -« -42 Theory C = 78.7%
IR ( 11 ) = See Appendix - 10.4%
Fig. 30
Found C = 78. 11%




Cholest-5-en-3§-ol-24-one (200 mg.) was dissolved
in 5 ml. of dry ether and added to a suspension of 200 mg.
of lithium aluminium hydride in 5 ml. of ether. The
mixture was refluxed for 30 minutes and then allowed to
cool. The excess reagent was decomposed with 15 ml.
of ether-ethyl acetate (2:1) and the produce worked up as
usual (p. 107). The product showed two main spots on
TLC, one corresponding to an authentic sample of
cholest-5-en-3j3, 24|3-diol and the other less polar.
-152-
Repeated crystallization with ethyl acetate and then
methanol gave pure cholest-5-en-3|3, 24p-diol.
m. p. = 174°
ii) From 3p-acetoxy-cholest-5-en-24-one (from fucosterol)
3(3-Acetoxy-cholest-5-en-24-one (200 mg.) was
reduced with lithium aluminium hydride and the product
worked up as above to give pure cholest-5-en-3f3, 24j3-
diol.
m. p. = 176* I R- APrla o.
Hg * ~46
Coprostan-3a , 7a-diol-24-one
3a, 7a-Dihydroxy-cholanic acid (chenodeoxycholic acid)
The compound was prepared from cholic acid by the
method of Fieser and Rajagopalan (1950) according to
Hoffmann (1963).
m,p. « 137-139*
W D = +9




3a, 7a-Dihydroxy-5|3-cholanic acid (5 g,) was
acetylated with acetic anhydride (10 ml,) and pyridine
(2 ml.) at room temperature. The product was poured
into ice, extracted with ether, washed, dried,
evaporated and crystallized from methanol-ether (9:1)
which gave needle-like crystals (4.9 g.). The compound
is acidic and runs as a single spot on TLC (benzene:
ethyl acetate, 2:1),
m.p. * 118-122.
IR ( V ) = See Appendix CZSH44O4 requires C = 7 0. 58%
Fig. 31
H = 9.24%
Found C = 70. 08%
H = 9.05%
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3a, 7a -Diacetoxy- cholanyl chloride
3a, 7a-Diacetoxy-cholanic acid (3.5 g.) was
treated with oxalyl chloride (7 ml.) for 2 hours. The
product was worked up as usual. The white powdery
mass was used for the next step.
Required CI = 8. 7%
Found = 7.9%
3a, 7a -Dihydroxy-coproatan- 24-one
A Grignard reagent in ether was prepared from 2-
bromo-propane (8 ml.; 9.6 g.), magnesium turnings
(1.5 g.), ether (70 ml.) and cadmium bromide (20 g.)
as usual (p. 144). 3a, 7a-Dihydroxycholanyl
chloride (3, 0 g.) in benzene (6 ml.) was added to the
Grignard reagent and the mixture refluxed for 1 hour and
left at room temperature overnight. It was worked up
y ■
as usual (p. 145) and the product hydrolysed with
methanolic KOH (35 ml. of 5% methanolic KOH solution)
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by refluxing for 1 hour. The hydrolysed product was
extracted with ether and the dried extract evaporated to
dryness. The product at this stage showed two less
polar materials and a trace of some more polar
substance on TLC (benzene:ethyl acetate:acetone.
10:5:3). It was dissolved in benzene and chromato-
graphed on 'neutral' alumina (p. 43), The column
was washed first with petroleum ether and the compound
eluted with 10% benzene and then 20% benzene in
petroleum ether. The two eluates gave one spot on
TLC (Rjr = 0 35} benzene:ethyl acetate:acetone,
10:5:3). The eluates were evaporated to dryness.
Different solvents were tried for crystallization but
the compound could not be crystallized. It always gave
a gummy residue. The residue was then dissolved in
ether and evaporated. This process when repeated
three times gave a powdery mass which was shown to
have one component on TLC; the infrared spectrum
has clear peaks and shows hydroxyl and carbonyl
absorption. CzjHtfOs requires C = 77. 5%
mo = 74-76,p* - ' H = 11.0%
IR( V ) = See Appendix Fig. 3 2 Found C = 76 61 %
H = J0'<?8 %
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Coprostan-3a, 7 a-diol
3a, 7a -Dihydroxy-coprostan-24-one (0. 5 g,),
triethylene glycol (10 ml.), hydrazine hydrate 95%
* «. . i • ' " * i t • ' • - >■ '< • I I . ' ' i
'
(1.0 ml.) and potassium hydroxide pellets (0.8 g.) were
refluxed gently at 150* lor 45 minutes. The condenser
was removed and the solvent allowed to evaporate until
the temperature reached 195*. An air-condenser was
then fitted and the reaction mixture heated at 195* for
2 hours. The cooled reaction mixture was poured into
0. 5N-HC1 (75 ml.) with constant stirring. The
resulting precipitate was extracted with ether, washed,
dried and evaporated. The residue showed a trace of
the starting material on TLC (benzene:ethyl acetate:
acetone, 10:5:3) which was removed by crystallization
of the product with petroleum ether-ethyl acetate.
The product came down as a gummy residue while the
trace of the impurity stayed in the supernatant (shown
by TLC of the supernatant and the residue). Several
attempts at the crystallization gave solid plate-like
crystals (m,p. = 78-79). The melting point showed
mjj.
SULPHURIC ACID SPECTRA OF DIFFERENT SAMPLES OF COPROSTAN- J*/*- DIPL.
Figure 29
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no depression on admixture with an authentic sample
prepared by other methods (p. 114).
m,p. a 78*79* MtxedL *m.p. = 78-79
WJJ * 13#
1R ( V ) = See Appendix Fig. 11
The sulphuric acid spectra of the three samples of
coprostan-3a, 7a -diol obtained by different methods are
^ound to be identical (Fig. 29).
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A number of compounds hydroxylated in the side-
chain have been synthesized; 26-, 25-, and 24-hydroxy-
cholesterols have been obtained by different methods,
Coprostan-3a, 7a -diol-24-one, a compound which
could give considerable information about the mechanism
of the cleavage of the side-chain has been synthesized.
Cholest-5-en-3p, 26-diol has been labelled with
tritium.
Thin-layer chromatography has been used for





The progress achieved in this work is briefly
summarized in the following paragraphs.
i) A method has been developed whereby using
small quantities of reactants a quantitative study of
some steroid reactions can be made.
ii) A method of 7a -hydroxylation of 5. 6-unsaturated
steroids has been developed and using this method some
possible 7a -hydroxylated intermediates have been
synthesized. The syntheses proceed through hydro¬
peroxide intermediates which could be possible
biological intermediates also.
iii) A new route of synthesis of coprostan-3a, 7a-
diol from cholesterol which proceeds through the
possible biological intermediates has been developed;
cholest-4-en-3-one-7a-ol and coprostan-3-one-7a-ol
have been obtained as intermediates in this synthesis.
iv) Choiest-4-en-3a, 7a -diol, a possible inter¬
mediate. which has not been described before has been
synthesized.
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v) Coprostan-3a, 7a -diol-24-one, another
possible intermediate which has not been described
before, has been synthesized.
As a result of the study of the reactions involved in
the above mentioned syntheses, information has been
obtained on certain steroid chemical reactions.
i) Further proof is provided for the a -configuration
of the epoxide ring in cholest-4-en-3-one-6a, 7a-epoxide,
ii) Potassium borohydride reduction of cholest-
4-en-3-one-6a, 7a-epoxide at reduced temperatures
has been shown to reduce the keto group selectively;
a new compound, cholest-4-en-3a -ol-6a, 7a -epoxide,
has been synthesized.
-161-
The method of fluorescent thin-layer chromato¬
graphy which has been adapted for use in synthetic
steroid chemistry in this work has proved to be of
importance in different ways. It has been successfully
used as an additional check on the purity of most of
the steroids used in this work and for co-chromatography
of unknown steroids with standard samples. This
particular thin-layer technique has also been used in
checking different eluates obtained from column
chromatography and in following many reactions such
as in time-course studies. Valuable information about
the mechanism of certain reactions and specificities of
certain reagents has been obtained by following the
reactions by TLC.
When cholest-4-en-3-one-7a-ol was hydrogenated
at room temperature (p. 115), the TLC at every hour
showed several spots, one less polar than the starting
material and two or three more polar. The less polar
spot seemed to be diminishing as the reaction
-162-
proceeded, while the more polar spots increased.
This led to the belief that the less polar product was
possibly an intermediate, and due to its chromato¬
graphic behaviour and non-u. v. absorbing nature, it
was suggested to be coprostan-3-one-7a-ol. That this
compound was am intermediate and was indeed
coprostan-3-one-7a-ol m was shown by the synthesis
of this compound from the same starting material by
hydrogenation at -27*. Another example of obtaining
such information was the potassium borohydride
reduction of cholest-4-en-3*one-6a, 7a-epoxide (p. 1Q6)
where, with the help of this technique it was shown
that the complete reduction of the epoxide proceeded
through an intermediate cholest-4-en-3a -ol-6a, 7a-
epoxide. These two examples also showed the
respective specificities of the hydrogenation and
potassium borohydride reduction reactions at reduced
temperatures; hydrogenation at -27* reduces the
double bond only while potassium borohydride at -5*
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reduces the ketone in preference to the epoxide group.
Several other examples where TLC has given
additional information about the reactions have been
described in the text.
However, by this technique of fluorescent TLC,
all studies are qualitative and it does not give as much
information about the reactions as would be available
if such studies were quantitative.
Thus, in this work a method has been developed
whereby using small amounts of the reactants a
quantitative study of the reactions can be performed
(p. 50). For this new method the fluorescent TI>C
has been coupled with radioactive counting and the
reactions are performed using labelled substrates.
This renders the method quantitative and gives
considerable additional information such as reaction
rates. It is also possible to establish the number and
amount of intermediates (or side products) in a
reaction at a certain time. The purity of labelled
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compounds can be checked and it can also be used lor
the study of compounds which do not give colour
reactions. In this work this technique has been
successfully used for the study of photo-sensitized
oxygenation reactions (pp. 68 & 73)and it has been shown
that using small quantities of reactants, a significant
amount of information can be obtained about the
mechanism of the reaction.
This technique, however, has the disadvantage
that substances must be eluted from the plates for
........ , . . . ; , ; .... I
scintillation counting. To avoid this procedure of
elution, the use of a chromatogram-scanning device
could be considered. This will no doubt be a quicker
and easier method but could not be as efficient as the
liquid scintillation counting system used in this workj
the efficiency of certain known chromatogram- scanners
is very low compared with the 80% and 40% efficiency
obtained for CM and H5 respectively on the liquid
scintillation counting system. The latter system was
thus preferred and has given good results.
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This method of the study of steroid reactions seems
to have great promise in synthetic organic chemistry.
The classical methods of studying organic reactions
are tedious and not so precise. They usually rely on
some method of estimation (like gravimetry) of the
product and need relatively large amounts of the
reactants and the product has to be worked-up before
it can be estimated. The method described in this
work, on the other hand, does not require any other
specific methods of estimation of the products and can
be used for very small quantities of the reactants;
the product does not have to be worked up and so losses
are cut down to a minimum. This method is thus
more precise and easier and can give an almost
'minute- to-minute1 account of the reaction.
Since this method is quantitative it can also be
used for kinetic studies. But* since the purpose of
this work was the synthesis of possible physiological
degradation products of cholesterol and the main
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interest was to study the time courses of certain
reactions and to find out about the side-products and/or
intermediates, if any, these studies were kept
limited to these problems and the results obtained were
not interpreted mathematically for the kinetics of the
reactions. The data obtained could, however, be
used for such interpretations.
It has been pointed out in the introduction that in
the degradation of cholesterol to bile acids the initial
attack is at C7 and this hydroxylation could proceed
through a hydroperoxide intermediate. 7a -Hydroxyl¬
ation of cholest-5-en-3(3, 26-diol and 3p-hydroxy-chol-
5-enic acid has been shown in biological systems. If
these hydroxylations were brought about by the same
mechanism then several 7a-hydroperoxy and the
corresponding 7a -hydroxy compounds would be inter¬
mediate.
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In this work a method has been developed whereby
7a-hydroxylated derivatives have been synthesized
through an intermediate photosensitized oxygenation
reaction. The syntheses proceed through hydro¬
peroxide intermediates, thus perhaps mimicing the
biological hydroxylations. This method of 7a-
hydroxylation, besides proceeding through the
possible biological intermediates, has the advantage
that it can be applied to a number of steroids. Use
has been made of the 5, 6-double bond which makes the
allylic position 7 very reactive and the hydroperoxida-
tion of such steroids being a stereospecific replace¬
ment reaction (Nickon and Bagli, 1961), the hydro¬
peroxide group is introduced specifically into the 7a -
position. The existing methods of 7a -hydroxylation
through an allylic bromination or an allylic oxidation
at C7 with the subsequent hydrolysis of the bromo
compound or the reduction of the 7-ketone, do not
give good yields and also the hydroxyl at 3(?-position
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has to be protected. In the photo*sensitized
oxygenations, on the other hand, the hydroxyis need
.
not be protected since the oxygen attack is stereo*
I
specific at the 7a-position and under these conditions
the hydroxyis are not attacked. Therefore, this
method of 7a-hydroxylation was applied to other
hydroxylated 5, 6-unsaturated steroids besides
cholesterol. It has been successfully used for the
synthesis of cholest-5-en-3|3, 7a*diol and cholest-5-
en-3P, 7a-26-trioi through the respective hydroperoxide
intermediates. Preliminary experiments with methyl-
3(3-hydroxy-chol-5-enate have shown that this compound
can be photo*oxygenated to produce the corresponding
7a -hydroperoxy derivative which could be reduced to
the 7a -hydroxy compound. This compound could not
be isolated due to paucity of material.
The hydroperoxides are very unstable compounds
and decompose very easily to give several products
(Kornblum et al. 1951). Fortunately, the hydro*
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peroxides synthesized in this work were found to be
stable on TL.C, Thus, it was thought that these
compounds would be stable on 'deactivated' silicic
acid (p. 45) because this preparation of silicic acid
: C "... •. . r 'i ! 4 "• • :
has almost the same 'activity' as that of silica gel on
thin-layer. Chromatography of these hydroperoxides
on this grade of silicic acid gave a pure product.
This finding is of interest because the hydroperoxides
have been thought to be unstable on adsorbents such as
alumina or silicic acid and that is why all purifications
usually
of these compounds have Jbeen accomplished by
crystallization procedures. The reduction of the
hydroperoxides gave the corresponding hydroxy
compounds.
Cholest-5-en-3{3, 7a -diol was shown to be pure by
TLC and comparison of the product with an authentic
sample prepared by a published method (Henbest and
Jones, 1948). The infrared absorption spectrum
shows large hydroxyl peaks and unsaturation, and the
two infrared spectra from the two samples are
identical.
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Cholest-5-en~3p, 7a, 26-triol shows large
hydroxyl peaks and unsaturation in the infrared
spectrum. An infrared spectroscopic examination
(kindly done by Dr J. Page of Glaxo Laboratories) was
found to be identical with the spectrum obtained on the
Infracord. Recrystallization of the compound did not
raise its melting point and it ran as a single spot on
TLC.
As discussed earlier (p. 19), cholest-5-en-
3p, 7a, 12a-triol is a possible intermediate. This
compound can be synthesized from 12a -hydroxy-
cholesterol (Danielsson, 196le) using the above
method.
It is known that the tertiary hydrogens in an
organic molecule are more reactive than the secondary
and primary hydrogens. cis-Decalin forms a hydro¬
peroxide at one of the tertiary carbon atoms (C9)
replacing the hydrogen with a hydroperoxide group,
showing that hydroperoxidation can occur on a
-171-
saturated tertiary carbon atom. The cholesterol
molecule has several such reactive centres and if
the biological hydroxylations are mediated through
hydroperoxide intermediates, it would seem
reasonable to assume that these positions will be most
prone to attack. Of all the tertiary carbon atoms in
the cholesterol molecule, C25 is of interest in the
study of degradation of cholesterol to bile acids, (p. 3 8).
!
As has been discussed earlier, the Cy is a very
reactive centre and it is not surprising that the
initial attack may be at that position. Once the C7
has been attacked to form a hydroxyl, and if the other
hydroxylations occur through hydroperoxides, then an
attack at the tertiary carbon C25 would be most likely.
|
_
Choiest-5 -en-3{3, 25-diol has been isolated in in vitro
studies (Fredrickson> .1956).. This,
however, does not disprove that a 25-hydroxylation is
one of the stages of degradation of the cholesterol side-
chain. It may be that 7a -hydroxylation has to precede
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the 25-hydroxylation and in such a case cholest-5-en-
3(3, 7a, 25-triol would be an intermediate. This
compound can be synthesized from cholest-5-en-3p, 25*
diol by the above method of 7a -hydroxylation.
Choiest-5-en-3£, 7a, 24-triol, which is another possible
intermediate (p. 25), can be synthesized from choiest-
5-en-3^, 24-diol. These two starting diols, cholest-
5-en-3(3, 24-diol and choiest-5-en-3(3, 24(3-diol have
been synthesized by known methods discussed later.
The sequence of reactions used in this work for
the synthesis of coprostan-3a, 7a-diol from
cholesterol (p. 10°) is based on the fact that the
secondary 3p-hydroxyl of cholesterol is in a homo-
allylic position to the 5, 6-double bond and so can be
oxidized by an Oppenauer method. The other
hydroxyls, if any, in the molecule are not affected.
The epoxidation of the product of the Oppenauer
oxidation, cholest-4, 6-diene-3-one, by mono-
perphthalic acid is also a selective oxidation for this
double bond (A6). Several reactions are known where
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monoperphthalic acid has been used for selective
epoxidation of double bonds in steroids having hydroxyl
functions or ester groups in the molecule (for references
see Fieser and Fieser, 1959). The reduction of the
epoxide with lithium aluminium hydride does not affect
any hydroxyls and the reoxidation of the reduced product
with manganese dioxide is again a selective oxidation for
the hydroxyls allylic to a double bond. The formation of
coprostan-3-one-7a-ol by selective reduction of the
double bond in cholest-4-en-3-one-7a-ol at reduced
temperatures does not affect any hydroxyl groups. The
carbonyl of the coprostan-3-one-7a-ol has been reduced
with metal hydrides to give coprostan-3a, 7a-diol.
All the reactions described are selective and would
leave the other hydroxyls, if any, untouched and thus the
method can be applied to other hydroxylated ^-steroids.
The methods of synthesis of cholest-5-en-3p, 26-diol
'Scheer etal. 1956), cholest-5-en-3£, 12a -diol
Daniels son, 1961e), cholest-5-en-3p, 25-diol (Dauben et
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al. 1950; Ryerjstal. 1950) and cholest-5-en-3p, 24-diol
(Riegel and Kaye, 1944) are known, and using these
substances as the starting materials, a whole series of
possible intermediates can be synthesized. Some such
possible intermediates are li&ted on page s 19 and 29.
Nickon and Bagli (1961) first prepared cholest-4-en-
3-one-6a, 7a-epoxide and indicated that the a - configuration
of the epoxide was arbitrary and was based on analogy with
known reactions (Nussbaum et al. 1958), The synthesis
of cholest-4-en-3-one-7a-ol and some of its derivatives
from this epoxide has lent a direct proof for the a -
configuration of the epoxide group. The production of
:holest-4-en-3-one-7a -ol also shows that the reductive
cleavage of the epoxide ring with lithium aluminium hydride
does not proceed with an inversion like in some cyclo-
hexane epoxides (Trevoy and Brown, 1949). The reason
lor this seems to be the fact that in cyclohexane the ring is
(ree while the ring B of steroids is rigidly fixed and the
reductive fission does not proceed with inversion.
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Studies on metal hydride reductions of cholest-4-en-
3-one-6a , 7a - epoxide have shown that the reaction was
.
faster with lithium aluminium hydride and resulted in a
complete reduction to the two isomeric diols. The
reduction with sodium or potassium borohydride, on the
other hand, proceeded much more slowly, and the epoxide
was not reduced completely; studies using thin-layer
chromatography showed that the reaction proceeded
through the intermediate formation of a compound more
polar than the starting epoxide and less polar than the
diols. Its chromatographic behaviour suggested that
it had one nuclear hydroxyl with some other less polar
substituent; it was not u.v. absorbing and gave a light
brown colour with phosphotungstic acid. The reduction
of the epoxide with potassium borohydride at reduced
temperature (-5*) gave this compound in good yields.
Its infrared spectrum does not show a peak characteristic
of ketones but gives a hydroxyl peak (Fig. 7 Appendix) and
it is not u.v, absorbing which shows that the 3-ketone
has been reduced. Manganese dioxide oxidation gives
-176-
the starting epoxide showing the allylic unsaturation at
4, 5 and the presence of the epoxide group. The 3a-
configuration of the hydroxyl is proved by treatment with
.
digitonin which did not precipitate the compound. This
compound when reduced with lithium aluminium hydride
gave the diol cholest-4-en-3a, 7a-diol. This proves
that the compound is cholest-4-en-3a -ol-6a, 7a -epoxide
and shows that potassium borohydride reduces the
ketone in preference to the epoxide group and also that
I 1 . , ( ' j «1 i i ■
the reduction with this reagent gives the 3a -isomer as
the major product. The reduction of 3-ketones with a
. . . .
bulky hydride reagent would be expected to give the
equatorial 3(3-isomer as the major product. McKennis
and Gaffney (1948) and Plattner et al. (1948) showed that
the reduction of steroid A4-3-ketones with lithium
. ; . .,,■ ... " ,< • •' •• ; ;
aluminium hydride gave a 1:1 mixture of the two 3a-
and 3p-hydroxy isomers. In the case of the reduction
of cholest-4-en-3-one-6a( 7a-epoxide it has been shown
in this work that the lithium aluminium hydride reduction
-177-
gives a mixture of diols but potassium borohydride gives
the axial 3a •isomer. The reason for this seems to
be that the epoxide group at the rear of the molecule
prevents an attack of the metal hydride reagent from
that side and the attack is frontal to give the 3a-isomer.
The selectivity of this attack is increased when lithium
aluminium hydride is replaced with a bulkier reagent
like potassium borohydride.
. ; „ /: j; •
Cholest-4-en-3a, 7a-diol, a possible intermediate
'
, • ' •
t . ... .. ■ • - •• ■ •
in the degradation of cholesterol (p. 17) has not been
described before. This compound has been synthesized
. v . . • ■ : ' ■ *' ! •' .. -' ,'1
and its structure shown by different methods. The
infrared absorption spectrum shows large hydroxyl
peaks and unsaturation. Manganese dioxide oxidation
gave a known compound, cholest-4-en-3-one-7a ~ol,
proving the presence of a hydroxyl allylic to a 4, 5-
double bond and a hydroxyl in the 7a -position. The 3a -
configuration of the hydroxyl is proved by non-
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precipitation of an alcoholic solution of the compound
with digitonin. This compound would be expected to
give coprostan-3a, 7a -diol on saturation; the hydroxyls
in the 3a - and 7a 'positions would hinder an attack from
the a-side and the reduction of the double bond would
give a 5|3-hydrogen giving coprostan- 3a, 7a-diol as the
product. It will be interesting to study the possible
conversion of this compound to bile acids in bile
fistula animals.
Choiest-4-en-3-one-7a -ol has been synthesized by a
new route. While this work was in progress,
Daniels son (1961a) published a method of synthesis of
this compound but the method developed in this work
gives much better yields and is applicable to other
hydroxylated steroids also. As discussed on page 100,
26, 25, 24 and 12a-hydroxylated derivatives of cholest-
4-en-3-one-7a-ol can possibly be synthesized using the
corresponding dihydroxy derivatives of cholesterol as
the starting materials. The compound has the same
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characteristics as the published data (Danielsson, 1961a).
Its structure is further proved by the synthesis of
derivatives like coprostan-3-one-7a-ol and coprostan-
3a, 7a -diol. These derivatives had the same
characteristics as the published data.
It has been discussed in the Introduction that
coprostan-3-one-7a -ol and coprostan-3a, 7a -diol are
possible intermediates in the degradation of cholesterol
to bile acids.
Cholest-4-en-3-one-7a-ol would be expected to
give coprostan-3a, 7a-diol on catalytic hydrogenation.
With the help of TLC in this work it was shown that this
reaction proceeded through the intermediate formation
of coprostan-3-one-7a-ol. This finding was used in
the selective reduction of the 4, 5-double bond of cholest-
4-en-3-one~7a-ol at -27* (cf. Grasshof, 1934; Nickon
and Bagli, 1961) to produce coprostan-3-one-7a-ol.
This compound was first prepared by Yamasaki et ad.
(1959a). Danielsson (1961b) published another
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synthesis of this compound but both these methods do
not give good yields and the starting material,
coprostan-3a, 7a -diol itself is difficult to synthesize.
The advantage of the synthesis described in this work
is also that the starting material is cholesterol itself
and the synthesis proceeds through the possible
biological intermediate cholest-4-en-3-one-7a -oi.
The structure of this compound, coprostan-3-one-7a -ol,
has been shown by comparison of the properties of the
compound with the published data. TLC gives one spot
whose mobility suggests the proposed structure; infra¬
red absorption spectrum shows hydroxyl and carbonyl
absorption; it forms coprostan-3a, 7a -diol on reduction
with lithium aluminium hydride.
Coprostan-3a, 7a-diol, another proposed inter¬
mediate, has been synthesized by different methods.
Catalytic hydrogenation of cholest-4-en-3-one-7a-ol or
cholest-4-en-3-one-6a, 7a-epoxide at room temperature
produced coprostan-3a, 7a-diol. The synthesis was
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found to be more effective if the starting material was
hydrogenated first at -27* and then at room temperature.
This seems to be due to the fact that at room
• ■' Vi \ " ■ ■ 1 ' ( -1 ; i i j '■ - >,-V»• '• ' . *• * V-- • « '• ' . 1 •
temperature the hydrogenation may reduce the 3-ketone
before the saturation of the double bond and in such a
case two isomeric products (3a -ol and 3£-ol) would be
obtained from the 3*ketone. But if the reaction is
conducted first at -27*, only the double bond is
reduced resulting in a saturated derivative, of the
'
coprostane series, the reduction of which will mainly
give the 3a-isomer since it is known that the
reduction of 3-ketones of the coprostane series gives
i.
mainly the 3a-isomer .
Coprostan-3a, 7a-diol was also obtained when
coprostan-3-one-7a-ol was reduced with lithium
aluminium hydride. Another new method of synthesis
'
was by a Huang-Minion reduction of coprostan-3a, 7a-




That the compounds obtained by the four methods
of synthesis were identical was shown by mixed melting
point determinations and comparison of the infrared
spectra; all infrared spectra are identical and show
large hydroxyls and no unsaturation. The samples
were also compared with an authentic sample of
coprostan-3a, 7o-diol prepared by electrolytic coupling
of chenodeoxycholic acid and iso-valeric acid
(Bergstrom and Krabisch, 1957).
Bergstrom and Krabisch (1957) and Yamasaki et al.
(1959) noticed that this compound did not crystallize
very well. Ih this work it was noticed that the
product obtained from the hydrogenation reactions when
evaporated gave a solid product having a higher melting
point (188-192*) but when it was crystallized from any
solvent the melting point was much lower (78-79*).
As Bergstrom and Krabisch pointed out, this lowering
of the melting point may be due to the molecule of
water of crystallization. The synthesis of this
-183-
compound from cholesterol via cholest-4-en-3-one-
7a-ol and coprostan-3-one-7a-ol is of interest since
it proceeds through the same intermediates as have
been proposed for the biosynthesis of this compound.
Several methods have been used to prepare some
possible intermediates with modifications in the side
chain. 26-, 25- and 24-hydroxylated derivatives of
cholesterol have been synthesized by known methods.
These compounds could serve as the starting materials
for the synthesis of a whole series of compounds by the
two methods described in this work. By the method of
7a -hydroxylation the three triols can by synthesized and
these compounds can also be used for the synthesis of 12a,
26-, 25- and 24-hydroxylated intermediates connected
with the inversion of configuration at C3 and saturation
of the double bond ( pp. 15 and 99).
Chclest-5-en-3p, 26-diol was prepared from the
plant sterol kryptogenin. Scheer et al. (1956) prepared
this compound from the same sterol through a
-184-
Clemmenaen reduction and a subsequent Huang-Minion
reduction of the product of this reduction. This second
reduction was found necessary because the 16-carbonyl
of kryptogenin is not very easy to reduce presumably
because the position-16 is shielded by the side-chain
and so is difficult to attack by the reducing reagents.
The 22-carbonyl on the other hand does not produce such
a problem. In this work the demmensen reduction of
kryptogenin was studied with the help of TL.C and it
was noticed that if the reaction was carried out for a
longer time (up to 2| hours), most of the 16-carbonyl
was also reduced. If the reaction was kept on longer
than 3 hours, some additional products were produced.
Thus 2 hours was taken as the standard time and the
product was worked up at that stage. It was found that
the isolation of the 26-hydroxycholesterol from the
product mixture was quite easy through the
chromatography of the acetylation product of the
- 185-
mixture. However, the chromatography of the
diacetates on alumina produced an interesting
observation; the diacetates seemed to undergo a
partial hydrolysis of the primary alcoholic acetate
group at Cjt, Although most of the product still
remained as the diacetate and the separation was quite
-
effective, about 12% of the product underwent a
partial hydrolysis and about 5% showed complete
"
hydrolysis. This latter observation does not agree
#
with the findings of Johns and Jerina (1963) who
.
indicated that the steroid primary alcoholic acetates got
hydrolysed while the secondary did not. The free
cholest- 5-en- 3(3, 26-diol was obtained by the hydrolysis
....
of the diacetate. This compound has been used for the
synthesis of cholest-5-en-3p, 7a, 26-triol prepared by
'■ ;-'1 "' ' : '•'' s ' ' ! ' '
the method of ?a-hydroxylation developed in this work.
j
Choiest-5-en-3p, 25-diol has been obtained from
25-keto-nor-cholest-5-en-3£s-ol. The product was
obtained in better yields when the purification was done
-186-
by chromatography. This compound was synthesized
because it can serve as a starting material for the
synthesis of other 25-hydroxylated intermediates using
the two methods developed in this work. This
compound is also of interest because this can be a
precursor of cholest-5, 24-dien-3£-ol (Desmosterol)
which has been shown to be a direct precursor of bile
i
; ' / ; v ; • / • _ \ ' •• , • ; .. t
acids. As discussed on page 3 8, there seems to be
a possibility that 25-hydroxylation may occur after 7a-
• ' i '•••••' •.
hydroxylation. Daniels son and Johansson (1964) using
Desmosterol as the substrate in their in vitro
experiments with the mouse liver homogenate have
reported the formation of a compound, whose
properties suggested it to be cholest-5, 24-diene-3p, 26-
diol. This is possible because the double bond at Cg*
would render the allylic position 26 very reactive for
a hydroxylation reaction. The hypothesis that
Desmosterol is a precursor of cholesterol has
recently been questioned (Goodman etal. 1963). In
-187-
view of the above observations it would be reasonable
to postulate that a 25-hydroxylation may be the first
stage of degradation of 7a -hydroxycholesterol and this
intermediate, cholest-5-en«3(3, 7a, 25-triol could
dehydrate to give cholest-5, 24-diene-3f?-ol which
would then hydroxylate in the allylic position Cj*.
Cholest-5-en-3£, 24-diol was prepared by two
methods. The known method of synthesis from
3p-hydroxy-chol-5-enic acid is tedious because of the
difficulties involved in preparing the starting material.
The synthesis proceeds through several stages;
purification and crystallization at every stage was
found to be quite difficult. Thus another method was
tried and the compound was obtained relatively easily
by ozonolysis of fucosterol and the subsequent
reduction of the 24-ketone with potassium borohydride.
These two samples were compared with an authentic
sample of cholest-5-en-3 {3, 24£-diol supplied by
Professor A. Ercoli.
-188-
The structure and purity of these three diols
(26* 25, 24) and the intermediates in their synthesis
have been shown by comparison with the published
data, their infrared spectra and behaviour on TLC -
they all gave single spots.
Cole and Julian (1945) found a method of preparing
steroids with a ketone in the side-chain, A new
compound, coprostan-3a, 7a -diol-24-one, has been
synthesized by this method (p. 155). The compound
could not be brought into a crystalline form although
several different solvents were tried for this purpose.
Evaporation of an ether solution of the compound,
however, gave a colourless powder which ran as a
single spot on TEC in two different solvent systems.
The structure of the compound has been shown by the
usual methods. TLC behaviour suggests the presence
of two hydroxyl groups and a less polar substituent;
it is less polar than the 3a,7a, 12a -trihydroxy-
coprostan and more polar than 3a, 7a -dihydroxy-
coprostan (solvent system - benzene:ethyl acetate:
acetone, 10:5:3), Its infrared spectrum shews a
large hydroxyl peak and a carbonyl absorption.
-189-
This compound is of interest in this work because
this could give some information about the mechanism
A
of the cleavage of the cholesterol side-chain. It has
been pointed out in the Introduction (p. 25) that in
the cleavage of the side-chain, 24-hydroxylation may be
involved and thus coprostan-3a, 7a, 24-triol may be a
possible intermediate. However, experiments using
compounds carrying a Cj*-oxygen function have shown
that these compounds are indeed converted into cholic
acid in bile fistula animals, but not as readily as the
corresponding compounds without a C^-oxygen,
Such studies have been performed on 3a, 7a, 12a-
trihydroxy coprostanic compounds with or without a
Cj[4-oxygen. The same studies using compounds not
already carrying a 12a-hydroxyl group will be of
greater significance since they can give information on
two important points.
It is known that compounds carrying an oxygen
function (hydroxyl or carboxyl) at €24 do not produce
-190-
cholic acid indicating that the 12a -hydroxylation does
not occur once the oxidation of the side-chain has
started. Such studies have not been done on compounds
carrying a Cj4-oxygen (hydroxy! or carbonyl) and no
12a-hydroxyl. The results with the latter compounds
may be quite different. Thus it will be of interest to
ascertain (a) if the coprostan-3a, 7a-diol-24-one or
the corresponding coprostan-3a, 7a, 24-triol are at all
converted into cholic acid and (b) whether they are
converted into chenodeoxycholic acid more or less
readily than coprostan-3a, 7a -diol or coprostan-3a, 7a, •
26-triol.
It will be interesting to perform the same sort of





Cholesterol is present in all mammalian cells, in
membrane and in sub-cellular particles in relatively
large amounts. It appears to be present among the
most primitive animals but only as one of several
sterols. In higher animals the proportion of cholesterol
to other sterols increases until it becomes the principal
sterol of the vertebrates. In the higher animals the
sterols, principally cholesterol, occur as free alcohols
or esterified with carboxylic acids and also associated
with other substances such as proteins to give lipoprotein
complexes. The sterols are continuously formed and
metabolized to other products in the animal and plant
cells.
Cholesterol itself is quite inert until it is activated.
This activation could occur in different tissues at
different particular positions of the cholesterol molecule
leading to the formation of a variety of metabolites.
If the activation occurs in the liver, the molecule
degrades in a particular manner to form bile acids and
• 192~
neutral sterols while if the activation occurs in
endocrine tissue the products are steroid hormones.
Activation in plants may lead to different types of
sterol; in the lower plants the molecule can add on one
' '
or two carbon atoms at C24 such as in fucosterol, but
in other plants activated at 16. 22 and 26 positions it
could form oxygenated derivatives which give a number
of other derivatives by dehydration and saturation.
The plant sterols with rings £ and F could arise in this
manner.
Thus, in short, the chemistry of cholesterol and
related sterols is of great importance in different
fields of study. In all the biological processes
described in the preceding paragraph, the oxygenations
or hydroxylations of the cholesterol molecule seem to
be very important reactions. As discussed in the
review of the subject (p. 31), there seems to be a
possibility that these hydroxylations are brought about
through hydroperoxide intermediates but there is no
direct experimental evidence to back this hypothesis.
The work described here has been undertaken on
a minor problem, viz. studies on some physiological
degradation products of cholesterol in the formation of
bile acids. As has been discussed in the text, there
are a number of possible routes for this degradation
and it is not known which of them is actually employed
in the biological processes. The sequence of the
degradative steps is not known and there is little
information available on the actual mechanism of these
reactions, for example the mechanism of hydroxylations
is not clear.
In this work an effort has been made to review the
j subject and show that there are still 'gaps' in our
knowledge of these processes.
The studies on these biological processes have
usually been performed through synthesized 'possible
intermediates'. Thus in this work a number of such
compounds which could be postulated as intermediates
in this degradation have been synthesized by different
methods:-
-194-
Hydroxylation at C7 of the cholesterol molecule has
been achieved by two different methods - viz. the
photo-sensitized oxygenations, through a hydroperoxide
intermediate, and with per-acids through an epoxide
intermediate. It has been shown that this method of
hydroxylation can be applied to a number of A9-steroids
and a whole series of possible intermediates can be
synthesized.
A new route for the synthesis of coprostan-3a, 7a -
diol has been evolved which proceeds through the
possible biological intermediates cholest-4-en-3-one-
7o-ol, and coprostan-3-one-7a-ol. This method of
synthesis is also applicable to a number of A5-steroids
having other hydroxyls in the molecule and using this
method series of possible intermediates can be
synthesized,
Cholest-4-en-3a, 7a-diol, another possible inter¬
mediate, not described before, has been synthesized.
Another new compound, cholest-4-en-3a-ol-6a, 7a -
epoxide is described.
-195-
A synthesis of coprostan-3a, 7a-diol-24-one is
described. This compound could be of importance in
the study of the mechanism of the cleavage of the
cholesterol side-chain.
Fluorescent thin-layer chromatography has been
used for following most of the reactions. A method has
been developed whereby steroid reactions could be
studied quantitatively with the help of fluorescent thin-
layer chromatography and scintillation counting.
The Wilzbach method of tritium-labelling has been
improved by giving the compound a shorter exposure
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